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Stem cells capable of self-renewal and differentiation into multiple tissues are important in 
medicine to reconstitute the hematopoietic system after myelo-ablative chemo- or 
radiotherapy. In the present situation, adult stem cells such as Mesenchymal stem cells 
(MSC) and Hematopoietic stem cells (HSC) are used for therapeutic purposes. For tissue 
regeneration and tissue constitution, engraftment of transplanted stem cells is a necessary 
feature. However, in many instances, the transplanted stem cells reach the tissues with 
low efficiency. 
 
Considering the three-step model of leukocyte extravasation by Springer et al, the rolling, 
adhesion and transmigration form the three major steps for the transplanted stem cells to 
enter the desired tissues. One of the molecular switches reported to be involved in these 
mechanisms are the Rho family GTPases.  
 
The present study investigates the role of Rho GTPases in adhesion and migration of 
stem and progenitor cells. Chemotactic and chemokinetic migration assays, 
transendothelial migration assays, migration of cells under shear stress, microinjection, 
retroviral and lentiviral gene transfer methods, oligonucleotide microarray analysis and pull 
down assays were employed in this study for the elucidation of Rho GTPase involvement 
in migration and adhesion of stem and progenitor cells.  
 
The transmigration assay used for the migration determination of the adherent cell type, 
MSC, was optimized for the efficient and effective assessment of the migrating cells. The 
involvement of Rho was found to be critical for stem and progenitor cell migration where 
inactivation of Rho by C2I-C3 transferase toxin and/or overexpression of C3 transferase 
cDNA increased the migration rate of Hematopoietic progenitor cells (HPC) and MSC. 
Moreover, modulation of Rho caused predictable cytoskeletal and morphological changes 
in MSC. 
 
Assessment of Rho GTPase involvement in the interacting partner, the endothelial cells 
during stem cell migration, revealed that active Rho expression induced E-selectin 
expression. The increased levels of E-selectin were functionally confirmed by the 
increased adhesion of progenitor cells (HPC) to the Human umbilical vein endothelial cell 
(HUVEC) layer. Moreover, inhibition of Rac in the migrating endothelial progenitor cells 
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(eEPC) increased their adhesion to HUVEC correlating with the increased percentage 
expression of cell surface receptor, CD44 in Rac inactivated eEPC. 
 
In conclusion, this study shows that Rho GTPases control the adhesion and migration of 
stem and progenitor cells, HPC and MSC. Rho inhibition drives the cells to migrate in the 
blood vessels. The substantial increase in the level of active Rho in endothelial layer, 
manifested by the E-selectin surface expression assists the better adhesion of stem and 
progenitor cells to the endothelial layer. Serum factors and growth factors in the 
physiological system influence the Rho GTPase expression in both migrating stem cells 
and the barrier endothelial cells. Thus, specific modulation of Rho GTPases in the 
transplanted stem and progenitor cells could be an interesting tool to improve the 
migration and homing processes of stem cells for cellular therapy in future.  
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ZUSAMMENFASSUNG 
 
Stammzellen zeichnen sich durch die Fähigkeit zu Selbst-Erneuerung und 
Differenzierbarkeit in unterschiedliche Gewebe aus. Dies macht sie zur Anwendung in der 
Medizin attraktiv. Gegenwärtig werden adulte Stammzellen wie mesenchymale 
Stammzellen (MSC) und hämatopoietische Stammzellen (HSC) zu therapeutischen 
Zwecken transplantiert. Mesenchymale Stammzellen werden seit einigen Jahren als 
interessantes Mittel zur Organregeneration z.B. des Herzens diskutiert, während 
hämatopoietische Stammzellen medizinisch zur Rekonstitution des hämatopoietischen 
Systems nach myeloablativer Therapie eingesetzt werden. Notwendig ist hierbei das 
Anwachsen der transplantierten Stammzellen im Empfänger; in vielen Fällen aber 
geschieht dies nur mit sehr geringer Effizienz.  
 
In diesem Zusammenhang interessant ist die Anwendung des dreischrittigen Modells von 
Springer et al. für die Auswanderung von Leukozyten aus den Blutgefäßen ins Gewebe 
auf Stammzellen, das Rolling, Adhäsion und Transmigration von Zellen als die 
entscheidenden Schritte beschreibt. Nach der Transplantation, die in der Regel in den 
Blutkreislauf erfolgt, wandern Stammzellen selbständig in die Blut bildenden Organe ein, 
die ihr eigentliches "Zuhause" im Körper sind. Ein wichtiger molekularer Schalter bei 
diesen "homing"-Mechanismen sind die so genannten Rho-GTPasen (ras-homologe 
Guanosin-Triphosphatasen). 
 
Die Rho-GTPasen sind eine Familie kleiner, monomerer Proteine in einer Größenordnung 
von ca. 25 kD, die in zwei Formen vorliegen können: Einer aktiven Form, die GTP 
gebunden hat, und einer inaktiven Form, die GDP gebunden hat. Beide sind durch 
Umwandlung von GTP in GDP bzw. Austausch von GDP gegen GTP ineinander 
überführbar. Liegt die Rho-GTPase in ihrer aktiven Form vor, wirkt sie an Signalwegen der 
G-Protein-gekoppelten Rezeptoren mit, die die Proliferation von Zellen, Differenzierung 
und Zellbewegungen regulieren. Die aktive, GTP-bindende Form der Rho-GTPasen wird 
von GTPase-aktivierenden Proteinen (GAPs) durch Hydrolyse des Triphosphats in die 
inaktive, GDP-bindende Form überführt. Diese wird durch Anlagerung von so genannten 
Guaninnukleotid-Dissoziationsinhibitoren (GDIs) stabilisiert, bis das GDP erneut gegen 
GTP ausgetauscht und die Rho-GTPase aktiviert wird. Dieser Austausch wiederum erfolgt 
durch so genannte Guaninnucleotid-Austausch-Faktoren (Guanin nucleotide exchange 
factors – GEFs). Rho-GTPasen spielen in vielen Signalwegen eine wichtige Rolle, unter 
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anderem bei der Regulation des Aktinzytoskeletts, das für die Morphologie und damit für 
die Migration von Zellen von entscheidender Bedeutung ist.  
 
Die vorliegende Arbeit untersucht die Bedeutung der Rho-GTPasen für die Adhäsion und 
Migration von Stamm- und Vorläuferzellen. Im Einzelnen geht es um den Einfluss von 
Rho-GTPasen auf das Migrationsverhalten von HSC und MSC und um die Regulation der 
Adhäsion von Stammzellen an endotheliale Zellen. Bisher wurde in Studien zum 
Migrationsverhalten mesenchymaler Stammzellen das Hauptaugenmerk meist auf die 
Verteilung der Zellen in Organen nach einer Transplantation gelegt. Im Gegensatz dazu 
steht hier die Migration nach Stimulation von Adhäsionsmolekülen und 
Chemokinrezeptoren selbst im Mittelpunkt. Erkenntnisse hierzu könnten helfen, die 
adhärenten MSC besser mobilisierbar zu machen. 
 
Ein wichtiges Mittel zur Untersuchung von Rho-GTPasen bietet die Natur: Eine Anzahl 
pathogener Mikroorganismen bildet natürliche Inhibitoren von Rho-GTPasen, auf denen 
ihre Pathogenität beruht. Zur Manipulation der Rho-GTPasen wurden in dieser Studie 
Toxin B, C2I-C3-Transferase und LT (lethal toxin) aus verschiedenen Clostridien- bzw. E. 
coli-Stämmen verwendet, die eine unterschiedliche Spezifität der Inhibition von Rho-
GTPasen aufweisen. Außerdem wurden dominant-negative oder konstitutiv-aktive 
Varianten von Rho-GTPasen in Zellen eingebracht, um den Effekt der aktiven bzw. 
inaktiven Variante einer Rho-GTPase auf die Zelle studieren zu können.  
In dieser Arbeit wurden drei Mitglieder der Rho-GTPasen untersucht: Rho, Rac und 
Cdc42. Alle drei sind an der Aktivierung des Zytoskeletts beteiligt: Rho induziert so 
genannte Stressfasern in Zellen sowie Fokale Adhäsionskomplexe, die bei der Anheftung 
von Zellen auf ihrem Untergrund von Bedeutung sind; von Rac und Cdc42 konnte gezeigt 
werden, dass sie die Bildung so genannter "actin ruffles" kontrollieren und Ausstülpungen 
der Zellmembran regulieren; alle diese Phänomene sind für Migration von Zellen wichtig. 
 
Die Versuchsbedingungen für Migrationsexperimente mit MSC - adhärenten Stammzellen 
- wurden zunächst optimiert, um das Wanderungsverhalten der Zellen effektiv erfassen 
und darstellen zu können. Hierbei gelang es, durch Vorbehandlung der für die 
Migrationsexperimente verwendeten Zellkulturplatten mit verschiedenen Substanzen der 
extrazellulären Matrix (Vitronektin, Laminin, Fibronektin) eine Versuchsanordnung zu 
etablieren, mit deren Hilfe chemotaktische, d.h. auf einen chemischen Reiz hin gerichtete, 
Migration von chemokinetischer Migration unterschieden werden kann, die keine Richtung 
zeigt. 
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Frühere Studien zeigten, dass für die Migration von HSC die Interaktion von SDF-1α mit 
seinem Rezeptor CXCR4 auf den Zellen essentiell ist. In dieser Studie wurde das 
chemotaktische Verhalten von MSC auf SDF-1α hin untersucht. Es konnte keine klare 
Migration von MSC auf SDF-1α hin festgestellt werden. Als Alternative zu SDF-1α wurde 
humanes Blutplasma verwendet, das in verdünnter Form in der Lage war, Migration von 
MSC zu induzieren. Es gelang allerdings noch nicht, den dafür verantwortlichen Faktor im 
Plasma zu identifizieren.  
 
Die Bedeutung von Rho für die Migration von Stamm- und Vorläuferzellen zeigte sich, als 
die Inaktivierung von Rho in den Migrationsexperimenten überraschenderweise die 
chemokinetische Migration von HPC und MSC signifikant erhöhte. Hierbei wurde eine 
spezifische Inhibition von Rho durch Verwendung von C2I-C3-Transferase, einem 
bakteriellen Toxin, erzielt. Eine generelle Inhibiton der Rho-GTPasen durch Toxin B, das 
Rho, Rac und Cdc42 inaktiviert, führte zu einer niedrigeren Migration von HPC auf SDF-
1α bzw. MSC auf Plasma hin, dasselbe wurde nach Verwendung von LT (lethal toxin) 
beobachtet, das Rac und Cdc42 inaktiviert, nicht aber Rho. Eine generelle Aktivierung der 
Rho-GTPasen durch LPA führte ebenfalls zu einer niedrigeren Migrationsrate der Zellen. 
Neben Plasma konnte auch eine Migration von MSC auf rhPDGF-bb und rhHGF hin 
gezeigt werden, die allerdings von der Aktivierung von Rho abzuhängen scheint. 
 
Außerdem bewirkte eine Modulation von Rho durch Expression dominant-negativer bzw. 
konstitutiv-aktiver Varianten deutliche Veränderungen in der Morphologie und im 
Zytoskelett von MSC. Die Zellen nahmen nach Inhibition von Rho eine gestreckte, flache 
Konformation an, die Ausformung so genannter Lamellipodien und Pseudopodien wurde 
nach einigen Stunden beobachtet. Interessanterweise führte die längerfristige Expression 
dominant-negativen Rhos in MSC zu einem anderen Phänotyp: Nach einigen Tagen 
wurde eine Häufung der Zellen beobachtet, eine Ablösung der Zellen von ihrem 
Untergrund und eine generelle Rundung ihrer Gestalt. Überraschend war, dass Ähnliches 
auch nach Expression der konstitutiv-aktiven Variante von Rho in MSC zu beobachten 
war, nicht aber nach Expression von aktivem Rac. Dies führt zu der Annahme, dass eine 
zweiphasische Regulation des Zytoskeletts durch Rho und Rac erfolgt. Es kommen aber 
auch adaptive Prozesse in den Zellen für eine Erklärung dieser Phänomene in Betracht. 
 
Neben der Migration ist für ein erfolgreiches Einwandern von Zellen ins Gewebe die 
Expression von Adhäsionsmolekülen, das "rolling" von Zellen auf dem Endothel und die 
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Anheftung der Zellen an endotheliale Zellen erforderlich, bevor es zum Durchtreten der 
Zellen durch das Endothel kommen kann.  
 
Um diese Vorgänge möglichst nah am physiologischen Sachverhalt untersuchen zu 
können, wurde eine "Flow Chamber" verwendet, eine schmale Kammer, in der ein 
konstanter Flüssigkeitsstrom definierter Geschwindigkeit den Blutstrom in den Adern und 
dessen Scherkraft simuliert. Diese Scherkraft, "shear stress", hat im physiologischen 
Sachverhalt großen Einfluß auf das "homing"-Verhalten von Zellen und sollte deshalb bei 
Untersuchungen hierzu nicht vernachlässigt werden. Am Boden der Kammer befindet sich 
eine Lage endothelialer Zellen aus Nabelschnurblut (HUVEC), die als Modell für das 
Endothel der Blutgefäße dienen. 
 
In dieser Arbeit wurde die Veränderung des "homing" von Stamm- und Vorläuferzellen 
unter verschiedenen Scherkräften und nach Stimulation mit dem Entzündungsmediator 
TNF-α untersucht, außerdem wurde die Rolle der Rho-GTPasen in diesem 
Zusammenhang beleuchtet. Dies geschah entweder durch Inhibition der Rho-GTPasen 
mit Hilfe der Toxine oder durch Überexpression dominant-negativer bzw. konstitutiv-
aktiver Varianten der Rho-GTPasen in den beteiligten Zellen, also in den HUVEC der 
endothelialen Lage oder den HSC bzw. MSC im Flüssigkeitsstrom. 
 
Die Analyse der Rho-GTPasen in Endothel-Zellen als den interagierenden Partnern der 
Stammzellen während ihrer Migration aus den Blutgefäßen in die Gewebe zeigte, dass 
eine erhöhte Rho-Expression mit einer erhöhten E-Selektin-Expression korrelierte. Die 
erhöhte E-Selektin-Expression im Endothel konnte funktionell bestätigt werden durch eine 
erhöhte Adhäsion von Vorläuferzellen an das Endothel. Nicht zuletzt erhöhte die Inhibition 
von Rac in migrierenden endothelialen Vorläuferzellen (eEPC) deren Adhäsion an 
HUVEC, korrelierend mit der erhöhten Expression des E-Selektin-Liganden CD44 in 
diesen Zellen.  
 
Somit lassen sich Migration und "homing" von Stammzellen als eine Sequenz von 
Phänomenen analog zur Extravasation von Leukozyten ins Gewebe beschreiben. Rho-
GTPasen spielen in den verschiedenen Stadien des "homing", "rolling", der Adhäsion und 
der Transmigration der Zellen eine wichtige Rolle. Die vorliegende Arbeit zeigt, dass durch 
Modulation von Rho-GTPasen die Einwanderung von MSC ins Knochenmark oder andere 
Organe verbessert werden könnte.  
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Während transplantierte MSC bisher aufgrund ihrer Morphologie oft in der Lunge der 
Empfänger hängen blieben und somit nur zu geringen Anteilen die Gewebe und Organe 
erreichten, für die sie bestimmt gewesen waren, könnte eine Inhibiton von Rho diese 
Zellen beweglicher machen, so dass sie die Lunge passieren und die Gewebe und 
Organe erreichen können. Auf dieser Grundlage könnten neue Therapieansätze zur 
Knochenheilung, Wundheilung und zur Regeneration untergegangenen Gewebes 
enstehen.  
 
Die Daten sprechen für ein Modell der Transmigration, in dem aktives Rac das "rolling" 
von Stammzellen (MSC) im peripheren Blut und ihre Extravasation durch das Endothel 
reguliert. Auf der anderen Seite führt an Orten von Entzündung oder Verletzung von TNF-
α aktiviertes Rho in endothelialen Zellen zu einer verstärkten Expression von E-Selektin 
im Endothel, was wiederum zu einer verstärkten Adhäsion von Stamm- und 
Vorläuferzellen führt. 
 
Wachstumsfaktoren wie PDGF (platelet-derived growth factor), die am Ort der Verletzung 
präsent sind, aktivieren nun Rac. Dies führt dazu, dass Stammzellen beginnen, durch das 
Endothel in das betreffende Gewebe einzuwandern. In allen Schritten dieses Modells der 
Transmigration wird eine reziproke Balance von Rac und Rho postuliert, in der Rac die 
Migration und Rho die Adhäsion von Stamm- und Vorläuferzellen bewirkt, was letztlich 
das "homing" der Zellen und ihre Einwanderung in das Gewebe reguliert. 
 
Zusammengefasst zeigt diese Arbeit, dass Rho-GTPasen die Adhäsion und Migration von 
Stamm- und Vorläuferzellen regulieren. Inhibiton von Rho führt zu erhöhter Mobilisation 
dieser Zellen in den Blutkreislauf. Die Zunahme der aktiven Form von Rho in den Zellen 
des Endothels, die sich in erhöhter E-Selektin-Expression auf den Zellen manifestiert, 
führt zu einer Erhöhung der Adhäsion von Stamm- und Vorläuferzellen an das Endothel. 
Wachstumsfaktoren und Faktoren im Serum beeinflussen die Expression von Rho-
GTPasen sowohl in zirkulierenden Stammzellen als auch im Endothel. 
 
Deshalb könnte eine spezifische Regulation der Rho-GTPasen in transplantierten Stamm- 
und Vorläuferzellen ein wichtiges Mittel zur Verbesserung der Transplantationseffizienz 
und damit der Stammzelltherapie insgesamt sein. 
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1.0 SCIENTIFIC  BACKGROUND 
 
1.1 Stem  Cells 
 
Stem cells are considered as “building blocks” of multicellular organisms. They have the 
potential of self-renewal and can differentiate into multiple lineages depending on specific 
signals. Stem cells could be obtained either from embryonic tissue (embryonic stem cells) 
or from adult tissues (adult stem cells). Embryonic stem cells (ES cells) are pluripotent 
cells derived from the inner mass of the blastocyst that can be cultured in vitro indefinitely 
in an undifferentiated state (Tuan, et al 2003). Adult stem cells could be found in many 
tissues of the body including hematopoietic, hepatic, mesenchymal, and epidermal tissue. 
Although adult stem cells are not pluripotent like ES cells, some stem cells have been 
termed multipotent, i.e. they are capable of differentiation in vitro and to contribute to 
multiple lineages other than their tissues of origin.  
 
Embryonic stem cells (ES cells) 
 
In medicine, stem cells have gained increasing attention due to the need for stem cells for 
the transplantation and regeneration of organs. For many reasons, ES cells isolated from 
human however have not entered into therapy. The first and the foremost reason are 
ethical considerations. The ES cells used to treat human diseases would have to be 
derived from human embryos. Although embryos used to produce ES cells were never 
destined to be re-implanted in the uterus, in most areas of the world it is an ethically 
unacceptable situation to destroy human embryos even for therapeutic purposes. 
Secondly, there are technical obstacles in the use of ES cells. Although several human ES 
cell lines have been established, they are not immunologically compatible with most of the 
patients. So a necessity occurs where separate ES cell lines would have to be made 
available for each patient by therapeutic cloning (Weissman 2002). However, cloning a 
patient’s DNA into existing stem cells is laborious and ethically contentious (Pearson 
2002). A third reason for not using undifferentiated ES cells is that they have been found 
to form teratoma (Orkin and Morrison 2002). Also, the differentiated cells derived from 
cultured ES cells have been seen to function inefficiently in in vitro studies (Lumelsky, et al 
2001). Recent studies report that a neo-antigen, sialic acid Neu5Gc, gets incorporated into 
the cultured ES cells, which may lead to the elimination of cultured ES cells by the 
immune system when used in the transplantation setting. Many humans were found to 
have circulating antibodies against Neu5Gc (Martin, et al 2005).  
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Multipotent Adult Progenitor Cells (MAPC) and Mesenchymal Stem Cells (MSC) 
 
The identification of MAPC through the years has allowed researchers to side step the 
disadvantages of ES cells (Jiang, et al 2002). MAPC were isolated from bone marrow of 
mice and rats and could be cultured in an undifferentiated state for up to 100 population 
doublings (Reyes, et al 2001) or 20 to 30 cell doublings in case of human cells (Prockop 
1997). Apart from bone marrow, multipotent stem-like cells were identified in brain (Taupin 
and Gage 2002), muscle (Majka, et al 2003), fat (Zuk, et al 2001) and liver (Campagnoli, 
et al 2001). Polymerase Chain Reaction (PCR), immunofluorescence staining, and 
retroviral marking methods have identified a single cell giving rise to continuous growing 
cultures and differentiated progeny. When transplanted into non-obese diabetic/severe-
combined immunodeficient (NOD/SCID) mice, these cells were found to engraft and 
differentiate into cells expressing different markers specific for various tissues e.g., bone, 
muscle, etc. (Jiang, et al 2002). In addition, blastocysts injected with these cells gave rise 
to chimeric progeny. No tumour or teratoma formation was seen in the immunodeficient 
mice that received the MAPC unlike in mice transplanted with embryonic stem cells 
(Jiang, et al 2002). Moreover, adult stem cells were found to maintain their differentiation 
potential throughout the life of the organism. Lineage or tissue type commitment of cells of 
mesenchymal origin is reversible (Cancedda, et al 2003). In addition, the adult stem cells 
do not create any substantial ethical considerations.  
 
Though adult stem cells were found to be therapeutically more feasible than ES cells, 
certain drawbacks occur in any cases. One disadvantage of MAPC so far is that only few 
groups have been capable of reproducibly isolating them. However, a similar and in many 
respects very comparable cell population, which is also of a fibroblastoid phenotype and 
which can be isolated from bone marrow are Mesenchymal Stem Cells (MSC) (Caplan 
and Bruder 2001, Pittenger, et al 1999). MSC are capable of differentiating into a number 
of different cell types, including neuronal progenitors (Bacigalupo 2004, Woodbury, et al 
2000) osteoblasts, chondrocytes, adipocytes or myocytes, fat or bone cells and in some 
cases to muscle cells (Saltiel 2003), as shown in Fig. 1.1. Systemically infused MSC were 
found to home to non-hematopoietic organs and might possess the capacity to proliferate 
within these tissues (Devine, et al 2003). 
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Fig.1.1 Schematic representation of hierarchy of MSC according to Caplan (Caplan and Bruder 
2001).  
 
Hematopoietic stem cells (HSC) 
 
Apart from MSC, a group of blood forming stem cells, was successfully isolated from 
human and murine tissues by various groups (Baum, et al 1992, Morrison and Weissman 
1994, Osawa, et al 1996, Spangrude, et al 1988). These are hematopoietic stem cells 
(HSC), defined by the combination of cell surface markers and by their ability to 
reconstitute the immune system of lethally irradiated mice.  
 
Using  in vitro culture techniques and in vivo HSC transplantation and bone marrow 
repopulation assays, a hierarchy of hematopoietic stem and progenitor cells has been 
defined. At the top of this hierarchy, a very small population of long-term bone marrow 
reconstituting HSC (LT-HSC) has been identified, which have the capability to reconstitute 
all hematopoietic lineages in an entire organism over a period of 3 months or longer 
(Uchida 1994, Uchida 1992) (see Fig. 1.2). Short-term repopulating HSC (ST-HSC) do the 
same, yet over a shorter time point. Cells with a high proliferation capacity, which are 
however not capable of self-renewal over extended periods or the lifetime of an animal, 
are termed committed hematopoietic progenitor cells (HPC). In addition to the above 
mentioned HSC types, multipotent (MPP), common lymphoid (CLP) or common myeloid 
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progenitors (CMP), as well as bi- or unilineage-determined progenitor cell types have 
been defined by the use unique of cell surface marker combinations (Fig. 1.2) (Passegue, 
et al 2003).  
 
 
Fig 1.2  Scheme of the hematopoietic hierarchy according to Passegue (Passegue, et al 
2003) showing HSC and HPC types in the course of hematopoietic lineage differentiation. 
LT-HSC: Long-term hematopoietic stem cells, ST-HSC: Short term hematopoietic stem cells, MPP: 
Multipotent progenitor cells, CMP: Common myeloid progenitor, CLP: Common lymphoid 
progenitor, MEP: Megakaryocyte Erythroid progenitor, GMP: Granulocyte macrophage progenitor. 
 
Furthermore, using in vitro clonal culture systems in semisolid media (hematopoietic 
colony forming assays), it has been possible to enrich and purify hematopoietic growth 
factors. This includes, colony-stimulating factors (CSFs; factors which when given alone 
stimulate the growth of colonies from HPC) including Granulocyte (G-), Macrophage (M-), 
GM- or Interleukin (IL)-3 which activates multipotent progenitors, and on the other side a 
number of synergistic factors such as Stem Cell Factor (SCF), FLT3 Ligand (FL), IL-1 and 
IL-6 (Metcalf 1984, Metcalf 1989). Whereas clonal semisolid culture systems have been 
shown to primarily indicate the presence of lineage-committed HPC, long-term culture 
systems which are supported by a stromal cell layer have been used to analyse the 
content of transplantable progenitor and stem cell populations of very primitive precursor 
cells, termed long-term bone marrow culture initiating cells (LTC-IC) (Dexter 1977, Eaves 
1988). 
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The role of stem cells in tissue replenishment and repair  
 
In recent years, the ability of stem cells and progenitor cells to circulate in the blood has 
been recognized to be of crucial importance for a number of physiological processes such 
as tissue repair, regulation of the size of the hematopoietic stem cell compartment, tumour 
metastasis formation, and vasculogenesis. Hematopoietic stem cell transplantation has 
evolved as a routine therapeutic procedure for a number of patients with human 
malignancies including leukaemia and lymphoma, if a suitable allogeneic donor is 
available (Thomas 1999a, Thomas 1975). Experimental animal studies using monkeys or 
mice have demonstrated that the best and clinically safe way for the application of 
transplanted stem and progenitor cells is the intravenous route (Thomas 1970, van 
Bekkum 1978) where the transplanted stem cells extravasate from the blood stream to 
certain tissues. HSC have been shown to home to the sites of hematopoiesis within the 
first hours to days after transplantation. However, only a proportion of the transplanted 
HSC or HPC could be retrieved from bone marrow and spleen in several different models 
(Oostendorp, et al 2000, Quesenberry 1999, Szilvassy 1989). Similar results have been 
reported after transplantation of human HSC (van Hennik 1999) or murine MSC in 
immunodeficient mice (Anjos-Afonso, et al 2004). In patients with ischemic disease, such 
as myocardial infarction or stroke, support by stem or progenitor cells is sought for 
improved re-endothelialization and in consequence more rapid reformation of infracted 
vessels and the surrounding tissue. More recently, it has been demonstrated that some of 
the stem cells homing to the bone marrow are capable of differentiation into more cell 
types than hematopoietic, including epithelial and mesenchymal differentiation (Goodell 
1996, Goodell 2001, Krause 2001). Also, the adult stem cells were reported to seek out 
the damaged tissue and repair them (LaBarge and Blau 2002, Pereira, et al 1998). 
However, in an application for bone repair, intravenously administered progenitor cells 
have been found to engraft with very low efficiency, indicating a potential defect in the 
homing of the transplanted cells (Cancedda, et al 2003).  
 
1.2  Adhesion molecule(s) and mechanisms regulating the extravasation of 
circulating cells through endothelium 
 
Hematopoietic stem cells (HSC) have been established to rescue the hematopoietic 
system after transplantation into patients with hematopoietic malignancies undergoing 
myelo-ablative chemotherapy or irradiation (Thomas 1999b). They were found to home to 
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the bone marrow and to initiate a new hematopoietic system, but the mechanisms which 
regulate their homing behaviour in many respects remained unclear. However, it can be 
inferred from mechanisms which regulate leukocyte extravasation to inflamed tissues that 
the engraftment step involves transplanted cells crossing the bone marrow endothelium to 
make their way into the bone marrow to its niche (microenvironment) using specific types 
of adhesion molecules. In this model, homing is an active migration process, and it 
involves 3 steps where the transplanted cells: 
1)  roll on the endothelium mediated by selectins,  
2)  adhere firmly to the endothelial layer through integrins and  
3)  transmigrate across the endothelium into the bone marrow in co-operation with 
chemokines (Springer 1994). 
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Fig. 1.3 Representation of various steps (Rolling, Adhesion and Transmigration) involved in 
the homing of transplanted cells. Model according to Springer (Springer 1994).  
 
 
As shown in Fig. 1.3, the transplanted cells in in vivo tether and roll on the endothelial 
layer of the blood vessels. At some instance, the cells stop and adhere firmly to the 
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endothelial cell layer until they transmigrate through the endothelium. Several classes of 
adhesion receptors have been found to be involved in this process. These include lectin 
ligands named selectins (Frenette, et al 1998), integrins and other calcium-dependent 
adhesion molecules (CAMs) (Texeido 1992). Endothelial cells can express E-selectin and 
P-selectin (Weibel Palade bodies), leukocytes express L-selectin, and P-selectin was 
found in intracellular granules of platelets (α-granules) (Bevilacqua and Nelson 1993). The 
interaction of the migrating cells with the endothelial P-selectin was found to be mediated 
by P-Selectin Glycoprotein Ligand (PSGL) (Pouyani and Seed 1995). These selectins 
were found to mediate rolling of the cells, whereas integrins mediate adhesion and 
transmigration in co-operation with chemokines. Studies by several groups showed that 
very late antigen-4 (VLA-4) is an important homing integrin in hematopoietic stem cells 
(Quesenberry and Becker 1998) and other integrins involved in the process were α5β1, 
and β2 integrins (Verfaillie, et al 1994, Williams 1991). Some of the adhesion molecules 
so far have been found to be of relevance for the interaction of HPC with endothelial cells 
during the homing process as represented in Fig. 1.3. Peled et al demonstrated that SDF-
1α is involved in the transmigration of HPC (Peled, et al 1999). Thus understanding the 
endothelial adhesion molecules and their interaction with the stem cells will shed light on 
the mechanisms of stem cell homing. 
 
The work of a number of groups, pioneered by the studies of T. Springer and co-workers 
(Springer 1994), has revealed that transmigration is an important and complex process 
where a network of signal transduction pathways are triggered in the endothelium as well 
as in the migrating cells in co-operation with external chemokines which attract the cells. 
In addition to adhesion molecules, Stromal cell Derived Factor-1alpha (SDF-1α) has been 
identified as a powerful chemoattractant for bone marrow derived CD34
+ cells (HSC) 
which signals through CXCR4 receptor (Aiuti, et al 1997). Moreover, HSC have been 
suggested to migrate from the circulation into the bone marrow across the endothelium by 
passing through the intercellular junctions of endothelial cells (van Buul, et al 2002). In co-
operation with selectins, integrins and chemokine mediated transmigration; many other 
signalling pathways are triggered in both the migrating cells and the endothelium and the 
surrounding cells during transmigration and homing. G protein coupled receptors were 
found to be an important player in this process. Recently identified small G proteins, the 
Rho GTPases, were reported to regulate tightly chemotaxis, actin polymerisation, and cell 
migration in neutrophils (Gardiner, et al 2002, Weiner, et al 1999). 
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1.3  Rho family small GTPases 
 
Signalling through G proteins 
 
G proteins are a family of small cytoplasmic signalling molecules, which have been 
implicated in the control of a number of crucial cellular functions, such as cell growth, 
differentiation, gene expression, and cell movement. G-protein coupled receptors (GPCR) 
transmit signals to intracellular targets through G-proteins. GPCR as cell surface receptors 
are characterized by seven-transmembrane α-helices. These receptors undergo 
conformational change due to external ligand binding which allows G-protein to bind to the 
cytosolic domain of the receptor and thus become activated. Thus, G proteins act as 
physiological switches that regulate the activity of intracellular targets in response to 
extracellular signals (Cooper 2000). 
 
The role of Rho GTPase signalling in the biology of stem cells 
 
Rho GTPases have been described in the early 1990s as members of Ras super family of 
small guanosine triphosphatases (GTPases) (Hall 1998). Rho stands for Ras homologous 
proteins. They are monomeric GTPases with a molecular weight in the range of 25kD. 
These proteins cycle between an active GTP-bound form and an inactive GDP-bound 
form (Fig. 1.4). The active state is terminated by GTPase-activating proteins (GAPs) that 
stimulate GTP hydrolysis. The switch between the GTP and the GDP-bound form is 
catalysed by guanine nucleotide exchange factors (GEFs) (Kjoller and Hall 1999); 
(Rossman, et al 2005). The guanine nucleotide exchange inhibitors (GDIs) stabilize the 
inactive GDP-bound form, and thus prevent the interaction of Rho GTPases with the 
plasma membrane but not with the downstream targets. GEFs have multiple or single 
specific targets (e.g., Tiam was shown to be specific for Rac) (Kjoller and Hall 1999). 
These molecules significantly regulate Rho GTPases spatially and temporally (Fukata, et 
al 2003).  
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Fig. 1.4 Schema of regulation of Small GTPase activation showing that small GTPases alternate 
between inactive GDP-bound and active GTP-bound states. Adapted from (Mackay and Hall 1998). 
 
Rho proteins act as a molecular switch controlling a variety of signal transduction 
processes and are also involved in the regulation of actin cytoskeleton (Raftopoulou and 
Hall 2004). These small Rho GTPases are involved in the control of cell-cell contact, 
integrin signalling (Hotchin and Hall 1996), endocytosis, proliferation (Westwick, et al 
1998), apoptosis (Malliri and Collard 2003), transcriptional activation, endothelial cell 
permeability (Wojciak-Stothard, et al 2001) and cell transformation (Bar-Sagi and Hall 
2000, Cleverley, et al 2000). The signalling processes contributed by Rho proteins are 
found to be important in host-pathogen interactions, signal transduction of cells in the 
immune system and host defence mechanisms. Rho proteins have also been found to be 
important for the invasiveness of bacteria in the gastrointestinal tract. Specific bacterial 
toxins have been shown to target Rho proteins in this context and thus mediate bacterial 
entry into mucosal cells (Aktories 1997).  
 
The three important members of the Rho family are Rho, Rac and Cdc42. The roles of 
individual Rho family members, Rho, Rac and Cdc42 in cell migration are interpreted to 
depend primarily on the regulation of actin dynamics and organization (Hall 1998). 
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Migration begins when a cell polarizes in response to a chemotactic or chemokinetic 
signal. Rounded or amoeboid modes of cell migration have been shown to require 
signalling through RhoA, whereas elongated mode of cell movement is driven by Rac. The 
migratory behaviour was characterized by a polarized interaction at the leading edge 
between collagen fibres with integrin β1 and matrix metalloproteinases co-clusters at 
these sites (Webb and Horwitz 2003).  
 
 
 
Fig. 1.5 Small G proteins in control of actin cytoskeleton according to Matozaki (Matozaki, et al 
2000). LPA: Lysophosphatidic acid, PDGF: Platelet derived growth factor 
 
Rho GTPases shuttle between the cytosol and specific membrane sites upon extracellular 
stimulation, such as growth factors and cell-adhesion molecules (Fukata, et al 2003). A 
post-translational modification, e.g. prenylation of the Rho proteins has been found to 
regulate their localization to different membrane compartments (Michaelson, et al 2001). 
The first molecule identified to activate Rho proteins was lysophosphatidic acid (Ridley 
and Hall 1992). LPA is a natural occurring water-soluble compound that was originally 
identified as a key molecule in de novo lipid biosynthesis (Moolenaar 1999, Moolenaar 
2000). It was also regarded as an important extracellular mediator regulating a broad 
range of biological functions. LPA was found to be stored inside the cells at concentrations 
up to 60 µM and could be released into the extracellular space (Goetzl and Lynch 2000). 
Rho, Rac and Cdc42 have been shown to be the master regulators of actin cytoskeletal 
activation (Ridley and Hall 1992). Rho activation has been shown to result in the formation 
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of focal adhesions and stress fibres (Ridley, et al 1992), whereas Rac participates in the 
control of lamellipodia (Ridley and Hall 1992) and Cdc42 in the formation of filopodia 
(Nobes, et al 1995). This is schematically represented in figure 1.5. Upon activation Rho 
becomes translocated to the plasma membrane and interacts with its effectors in the GTP-
bound form, whereas in the GDP-bound form where Rho is complexed with the GDI, it is 
restricted to the cytosol.  
 
 
 
Fig. 1.6 Rho protein family tree based on functional and biochemical relationships according to 
Sahai (Sahai and Marshall 2002) . 
 
A cross-talk between members of the Rho family GTPases has been described in primary 
cells (Bar-Sagi and Hall 2000). An increase in Rac level was found to down regulate the 
Rho activity (Rottner, et al 1999, Sander, et al 1999). Rac mediates the production of 
Reactive Oxygen Species (ROS) which inhibits the protein tyrosine phosphatase leading 
to the phosphorylation and thereby to the activation of p190RhoGAP which down 
regulates the Rho activity (Nimnual, et al 2003). Functional and biochemical relation 
between the members of the Rho family is represented in figure 1.6.  
 
The possibility to study the signalling pathways and morphological changes mediated by 
Rho GTPases has relied on the ability to interfere with activation of individual Rho 
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GTPases. The various approaches include: 
 
1.  Use of bacterial toxins that specifically target Rho GTPases (Aktories 1997) 
2.  Constitutively active and dominant negative isoforms of the Rho GTPases 
(Feig 1999) 
3.  Introduction of GTPase binding domains that inhibit Rho GTPases (Osada, et 
al 1997). 
4.  Small molecule chemical inhibitors that interfere with molecules in Rho GTPase 
pathway 
 
Bacterial toxins that influence Rho proteins. The toxins which have been used to 
influence the activity of Rho GTPases and their main characteristics are shown here in 
table 1.1.  
 
Toxin Source  Target  Mode  of  Action  Effect  Reference 
ADP-ribosyl 
transferase C3 
Clostridium 
botulinum type 
C and D strains 
Rho  ADP ribosylation at 
asparagine 41  Inactivation 
(Genth, et al 
1999) & 
(Genth, et al 
2003) 
Toxin B  Clostridium 
difficile 
Rho, Rac and 
Cdc42 
Monoglucosylation 
of Rho proteins at 
threonine-37 for Rho 
and threonine 35 for 
Rac and Cdc42 
Inactivation  (Aktories 
1997) 
Lethal toxin (LT)  Clostridium 
sordellii 
Rac and 
Cdc42 
Monoglucosylation 
using UDP-glucose 
as co-substrate 
Inactivation  (Aktories 
1997) 
Cytotoxic 
necrotizing 
factor 1 (CNF1) 
Escherichia coli 
(UPEC) 
Rho, Rac and 
Cdc42 
Deamination of 
glutamine 63 of Rho 
GTPase or 
glutamine 61 in Rac 
and Cdc42 
Constitutive 
activation 
(Waksman 
2002) 
 
Table 1.1 The bacterial toxins that target Rho GTPases. 
  
Clostridium botulinum type C and D strains produce ADP-ribosyltransferase C3 that 
targets the Rho proteins (Aktories and Hall 1989), (Genth, et al 1999). Several isoforms 
sharing 30-70% identity of C3 exist with a molecular mass of ~ 25 kD. The enzyme lacks 
cell binding and membrane translocation unit and usually enters the cells by diffusion. This 
enzyme modifies Rho (Rho A, Rho B, and Rho C) but not Rac or Cdc42. The modification 
occurs at asparagine 41 in the effector region of the GTPase, resulting in the inactivation 
of Rho leading to rounding up of cells, and inhibition of interaction of Rho with its effector 
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proteins. The toxin causes the redistribution of the actin cytoskeleton, thus making it a 
potent cytotoxin which is widely used as a selective inhibitor of Rho GTPase. A cell 
permeable form of the toxin C2I-C3 was used for the present study, because C3 was 
found inefficient in penetrating the cells. Clostridium difficile toxins B also target Rho 
proteins (Aktories 1997) which is designated as cytotoxin. Motifs of repetitive amino acid 
sequences are located at the C-terminus of Toxin B which is required for its binding to the 
carbohydrates of the eukaryotic cell surface. The middle part of the molecule comprises a 
short hydrophobic region probably involved in membrane translocation. The biological 
activity of toxin B has been found to be located at the N-terminus. Toxin B 
monoglucosylates Rho proteins using UDP-glucose as co-substrate. Monoglucosylation 
occurs at threonine 37 for Rho and threonine 35 for Rac and Cdc42, thereby blocking its 
interaction with the effector proteins. C. difficile toxins affect the actin cytoskeleton by 
inactivating the Rho proteins. C. sordellii produces lethal toxin (LT) that shares 90% 
similarity with C. difficile Toxin B and uses UDP-glucose as co-substrate. LT has been 
shown not to affect Rho, whereas it glucosylates Rac and thus inactivates it. Its ability to 
modify Cdc42 varies between toxins from various strains (Aktories 1997). 
 
Constitutively active and dominant negative mutants of Rho GTPases have been 
constructed analogous to the mutations identified in Ras proteins (Feig and Cooper 1988). 
Constitutively active mutants were created by mutagenesis of Gly→Val at codon 12 for 
Rac V12 (Xu, et al 1994) and Ala→Val at codon 14 for RhoA V14 (Qiu, et al 1995). These 
amino acids are conserved among the GTP binding proteins (Freeman, et al 1996) and 
mutations in these GTP binding domains or ‘effector regions’ were found to inhibit GTP 
hydrolysis (Xu, et al 1994). Dominant negative mutants were created by mutagenesis of 
Thr→Asn at codon 17 for Rac N17 (Bishop and Hall 2000) or Thr→Asn at codon 19 for 
Rho N19 (Qiu, et al 1995). Dominant negative proteins appear to function by sequestering 
GEFs (Kiyono, et al 1999) competing with the corresponding  endogenous GTPase, to 
form a complex which could not generate a downstream response (Feig 1999). 
Expression of these mutant GTPases were found to modulate actin organization and cell 
polarity in epithelial cells (Jou and Nelson 1998). 
 
So far, only few studies have been carried out to investigate the role of Rho GTPases in 
stem cell homing. All the three members of the Rho GTPases (RhoA, Rac1, Cdc42) have 
been reported to be ubiquitously expressed whereas Rac2 expression was found to be 
hematopoietic specific (Yang, et al 2001). On the other hand, Rac1 but not Rac2 was 
found to be important for the engraftment of HSC (Gu, et al 2003). Mice lacking Rac1 and 
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Rac2 showed increased mobilization of HSC from the bone marrow (Cancelas, et al 
2005). Moreover, expression of dominant negative RhoA in the bone marrow cells led to 
increased stem cell engraftment (Gu, et al 2003). 
 
Thus, the members of Rho family GTPases are candidates for the regulation of migration 
of stem cells populations. They might prove useful to understand the molecular 
mechanisms governing the migration and enhance the homing and engraftment of stem 
cells after bone marrow transplantation and may have a great impact on stem cell therapy. 
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2.0 AIMS 
 
 
Little is known so far about the role of small GTPases in the migration and homing 
behaviour of stem cells. In cellular therapy, the homing behaviour of HSC has been 
described after ex vivo manipulation, especially after culture steps. Moreover, since 1999 
MSC have become an additional attractive stem cell population for transplantation. 
However, homing and migration studies with MSC, have so far focused on the analysis of 
MSC distribution in the organs, and the response of MSC towards adhesion molecule and 
chemokine receptor stimulation is largely unknown. In addition, MSC represent a tightly 
adherent cell population, and it has been difficult to mobilize them to migrate in the 
chemotaxis system. Finally, the roles which endothelial cells play during the homing 
process await further elucidation. 
 
This study concentrates on the impact of Rho family small GTPases in stem and 
progenitor cell populations, as well as model type endothelial cells. It wishes to investigate 
and clarify  
 
1) the impact of Rho GTPase involvement in the chemotactic and chemokinetic 
migration of HSC, 
2) the possibility to mobilize adherent MSC to better migrate and response to 
physiological stimuli of migration, 
3)  the regulation of adhesion functions mediated by Rho GTPases in endothelial cells 
 
To interfere with Rho GTPase activation, the study is meant to use purified natural 
inhibitors of Rho GTPase as well as transfection and subsequent overexpression of 
dominant negative or constitutively active GTPase isoforms. The study aims to provide 
further insight into methods which will allow the manipulation and engineered targeting of 
potential therapeutic stem and progenitor cell populations for application in 
transplantations. 
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3.0  MATERIALS AND METHODS 
 
3.1 Materials 
 
3.1.1 Chemicals 
 
2-Propanol         Roth (# T910.1), Karlsruhe, DE 
Acetic acid, Glacial Hygroscopic   Sigma (# A-6283), Steinheim, DE 
Acetone      Roth  (#  9372.4),  Karlsruhe,  DE 
Acrylamide solution       Roth (# 3030), Karlsruhe, DE 
Agarose Type VII:  
-low gelling temperature      Sigma (# A-9045), Steinheim, DE 
Albumin, Fraction V      Sigma (# A-3059), Steinheim, DE 
Ammonium persulfate       Sigma (# A-3678), Steinheim, DE 
Ammonium Chloride      Sigma (# A-5666), Steinheim, DE 
Ampicillin      Sigma  (#  A-9518),  Steinheim,  DE 
β-mercaptoethanol      Fluka  (#63689),  Buchs,  CH 
Bombesin           Sigma (# B-4272), Steinheim, DE 
Bromophenol blue      Sigma (# B-5525), Steinheim, DE 
Calcium chloride (dihydrate)     Sigma (# C-3306), Steinheim, DE 
Chloroform        Sigma (# C-2432), Steinheim, DE 
Dry milk (non-fat)    Bio-Rad Laboratories (# 170-6404), Munich, 
DE 
Ethanol           Roth (# 5054.1), Karlsruhe, DE 
EDTA, disodium, dihydrate    Sigma (# E-9884), Steinheim, DE 
EZ-Detect Rac1 activation kit     Perbio Science (# 89856Y), Bonn, DE 
EZ-Detect Rho activation kit     Perbio Science (# 89854Y), Bonn, DE 
Gelatin Type A: from porcine skin   Sigma (#G-2500), Steinheim, DE 
Giemsa’s solution       Merck (# 00109204), Darmstadt, DE 
D-(+)-Glucose (anhydrous)    Sigma (# G-8270), Steinheim, DE 
Glycerol           Sigma (# G-5116), Steinheim, DE 
Glycine            Sigma (# G-8898), Steinheim, DE 
HEPES      Sigma  (#  H-7523),  Steinheim,  DE 
Hexamethrin bromide (polybrene)   Sigma (# H-9268), Steinheim, DE 
Hydrochloric acid         Roth (# 9277.2), Karlsruhe, DE 
Laemmli  sample  buffer  Bio-Rad Laboratories (# 161-0737), Munich, 
DE 
Lauryl Sulphate (SDS)      Sigma (# L-3771), Steinheim, DE 
Lysophosphatidic Acid (LPA)    Sigma (# L-7260), Steinheim, DE 
Magnesium chloride, Hexahydrate   Sigma (# M-2670), Steinheim, DE 
May Grünwald solution      Merck (# 1.01424.2500), Darmstadt, DE 
Methanol          Merck (# 1.6009.1011), Darmstadt, DE 
Mobi Glow Mounting medium    Mo Bi Tec (# MGM01), Goettingen, DE 
Nonidet P-40        Sigma (# N-7320), Steinheim, DE 
Parafilm M         Roth (# 20021151), Karlsruhe, DE 
Paraformaldehyde       Sigma (# P-6148), Taufkirchen, DE 
Phalloidin 
-FITC from Amanita phalloides    Sigma (# P-5282), Steinheim, DE 
-TRITC from Amanita phalloides   Sigma (# P-1951), Steinheim, DE 
Plasmid Maxi preparation kit     Genomed (# 220020), Löhne, DE 
PKH26 Red fluorescence kit    Sigma (# PKH26GL), Steinheim, DE 
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PKH67 Green fluorescence kit    Sigma (# MINI67), Steinheim, DE 
Ponceau S        Sigma (# P-7170), Steinheim, DE 
Potassium carbonate       Sigma (# P-4379), Steinheim, DE 
Potassium chloride        Sigma (# P-9333), Steinheim, DE 
Pre-stained SDS-PAGE standards, 
-Low molecular weight range   Bio-Rad  Laboratories  (#  161-0305),  Munich, 
DE 
-  Broad  range  Bio-Rad Laboratories (# 161-0373), Munich, 
DE 
Protein  detection  kit    Bio-Rad Laboratories (# 500-0006), Munich, 
DE 
Propidium iodide        Sigma (# P-4864), Steinheim, DE 
Sodium acetate, anhydrous     Sigma (# S-2889), Steinheim, DE 
Sodium azide         Fluka (# 71289), Buchs, CH 
Sodium bicarbonate       Sigma (# S-6279), Steinheim, DE 
Sodium chloride        Roth (# P029.2), Karlsruhe, DE 
Sodium hydroxide       Merck (# 6327139), Darmstadt, DE 
Sodium phosphate       Sigma (# S-7907), Steinheim, DE 
Shingosine-1-phosphate     Sigma (# S-9666), Steinheim, DE 
TEMED        Sigma  (#  T-7024),  Steinheim,  DE 
Triton X-100         Sigma (# T-6878), Steinheim, DE 
Trizma base         Sigma (# T-6066), Steinheim, DE 
Trizma Hydrochloride       Sigma (# T-5491), Steinheim, DE 
TRIzol reagent   Invitrogen Life Technologies (# 15596-018), 
Karlsruhe, DE 
Tween 20        Fluka  (#  93773),  Buchs,  CH 
Western blot detection kit     Upstate Biotechnology (# 17-318), Hamburg, 
DE 
Western blot detection kit (ECL plus)   Amersham BioSciences (# RPN2133),  
Freiburg, DE 
Y27632 in solution      Calbiochem (# 688001), Schwalbach/Ts, DE 
 
3.1.2 Toxins 
 
Cytochalasin D         Sigma (# C-8273), Steinheim, DE 
 
The Rho GTPase inhibiting toxins, C2I-C3, a cell permeable form of C3 transferase from 
Clostridium botulinum, Lethal Toxin (LT) from Clostridium sordellii Toxin B from 
Clostridium difficile were a kind gift from Dr. Klaus Aktories, Institute of Pharmacology, 
University of Freiburg, Germany. 
 
3.1.3 Protease  inhibitors 
 
Aprotinin from bovine lung       Sigma (# A-1153), Steinheim, DE 
Dithiothreitol           Sigma (# D-5545), Steinheim, DE 
Leupeptin Trifluoroacetate salt     Sigma (# L-2023), Steinheim, DE 
N-Ethylmaleimide         Sigma (# E-1271), Steinheim, DE 
Pepstatin A           Sigma (# P-4265), Steinheim, DE 
PMSF       Sigma  (#  P-7626),  Steinheim,  DE 
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3.1.4  Cell culture media and reagents 
 
BSA, V solution         Sigma (# A-1595), Steinheim, DE 
Chloroquine           Sigma (# C-6628), Steinheim, DE 
Dextran -FITC, 3000MW, anionic     Molecular Probes, USA 
DMSO       Sigma  (#  D-2650),  Steinheim,  DE 
DMEM 
-High glucose (4.5g/l)       PAA Laboratories (# E15-810), Cölbe, DE 
-Low glucose (1g/l)        PAA Laboratories (# E15-806), Cölbe, DE 
EBM-1       Clonetics  (#  CC-3156),  Oldendorf,  DE 
FBS  PAN Biotech (# 3302-P222303), Aidenbach, 
DE 
Fibronectin from human plasma     Sigma (# F-2006), Steinheim, DE 
Stock solutions of 1 mg/ml prepared in PBS and stored in small aliquots at -80°C. 
 
Ficoll separating solution      Biochrom (# L-6115), Berlin, DE 
Gelatin (From Porcine Skin)      Sigma (G-1890), Steinheim, DE 
HBSS             Gibco (# 24020-091), Karlsruhe, DE 
HEPES solution         Gibco (# 15630-056), Karlsruhe, DE 
Horse serum          Gibco (# 16050-122), Karlsruhe, DE 
HSA,  20%  solution       DRK-Blutspendedienst  Niedersachsen, 
Springe, DE 
IMDM       Gibco  (#  21980-032),  Karlsruhe,  DE 
Laminin from human placenta     Sigma (# L-6274), Steinheim, DE 
Stock solutions of 1mg/ml prepared in PBS and stored in small aliquots at -80°C. 
 
LB Agar (Lennox L agar)     Invitrogen life Technologies (# 22700-025), 
Karlsruhe, DE 
LB broth base     Invitrogen life Technologies (# 12780-052), 
Karlsruhe, DE 
Non-essential amino acid solution    Gibco (# 11140-035), Karlsruhe, DE 
Penicillin-Streptomycin solution    Gibco (# 15240-062), Karlsruhe, DE 
PBS         Gibco  (#  14190-094),  Karlsruhe,  DE 
PLL       Sigma  (#  P-4707),  Munich,  DE 
Protamin sulfate        Sigma (# P-4020), Steinheim, DE 
Red blood cell lysis buffer      Sigma (# R-7757), Taufkirchen, DE 
Retronectin      Takara,  Shiga,  Japan 
RNase I 
RPMI 1640          Gibco (# 21875-034), Karlsruhe, DE 
supplemented with L-Glutamine       
S.  O.  C.  Medium    Invitrogen life Technologies (# 15544-034), 
Karlsruhe, DE 
Trypan blue stain (0.4%)      Gibco (# 15250-061), Karlsruhe, DE 
Trypsin EDTA, 0.25% solution     Gibco (# 35400-010), Karlsruhe, DE 
Vitronectin from human serum     Sigma (# V-8379), Steinheim, DE 
Stock solutions of 1 mg/ml prepared in PBS and stored in small aliquots at -80°C.  
Water, endotoxin-free       Sigma (# W-3500), Steinheim, DE 
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3.1.5 Antibodies 
 
3.1.5.1  Antibodies used for Western blotting and Immunofluorescence 
 
Anti-mouse IgG-HRP       Sigma (# A-9917), Steinheim, DE 
Donkey anti-goat IgG-HRP      Santa Cruz Biotechnology (# sc-2020),  
Anti-mouse IgG-FITC       Sigma (# F-5262), Steinheim, DE 
Anti-Paxillin    BD Transduction Laboratories (Clone 349), 
Heidelberg, DE 
Anti-mVEGF R1 (Flt-1)       R & D Systems, Wiesbaden, DE 
Goat anti-human E-selectin      R & D Systems (# BBA18), Wiesbaden, DE 
Monoclonal anti-ß-Actin      Sigma (Clone AC-74), Steinheim, DE 
Monoclonal anti-Cdc42       Perbio Science, Bonn, DE 
Monoclonal anti-Rac1       Perbio Science, Bonn, DE 
Monoclonal  anti-Rho     Perbio  Science,  Bonn,  DE 
Monoclonal mouse anti-RhoA    Santa Cruz Biotechnology (Clone 26C4), DE  
Monoclonal mouse anti-Rho Clone 55   BD Transduction laboratories, Heidelberg, DE 
Polyclonal anti-human E-selectin    R & D Systems (# BBA18), Wiesbaden, DE 
Polyclonal Rabbit anti-Goat IgG/FITC   Dako Cytomation, Hamburg, DE 
 
3.1.5.2  Antibodies used for flow cytometric analysis 
 
The following antibodies from BD Pharmingen were used with the indicated 
chromophores: 
Antibody Chromophore  Clone/Isotype  Species  Cat.  No 
CD3 PE  HIT3a/Mouse  IgG2a,k Mouse  anti-human  555340 
CD11b/Mac-1  PE  M1/70/Rat (DA) IgG2b, k  Rat anti-mouse  553311 
CD117/c-Kit R  PE  2B8/Rat IgG2b, k  Rat anti-mouse  553869 
CD31/PECAM-1 -  MEC13.3/Rat  IgG2a,k Rat  anti-mouse 01951D 
CD44 FITC IM7/Rat  IgG2b, k  Rat anti-mouse  01224D 
CD45/LCA Cy-chrome  30-F11/Rat  IgG2b, k  Rat anti-mouse  011184 
CD45R/B220 PE  RA3-6B2/Rat  IgG2a,k Rat  anti-mouse  553089 
CD49d/Int α4 FITC  R1-2/Rat  IgG2b, k  Rat anti-mouse  01274D 
CD62L/L-sel PE  MEL-14/Rat  IgG2a,k Rat  anti-mouse  01265B 
CD54/ICAM-1  PE  3E2/Rat IgG, group 1, k*  Hamster anti-mouse  01545B 
CD73 PE  AD2/Mouse  IgG1,k Mouse  anti-human  550257 
CD105 - 266/Mouse  IgG1,k Mouse  anti-human  555690 
CD135/Flk-2  PE  A2F10.1/Rat (WI) IgG2a,k Rat  anti-mouse  553842 
Gr-1 PE  RB6-8C5/Rat  IgG2b, k  Rat anti-mouse  553128 
IgG2a, k  FITC  MOPC-21  Mouse  11024C 
IgG2b, k  PE  A95-1  Rat  11185A 
Sca-1 FITC  E13-161.7/Rat  IgG2a,k Rat  anti-mouse 553335 
TER-119 PE  TER-119/Rat  IgG2b, k  Rat anti-mouse  553673 
VEGFR2/Flk-1 PE  Avas12α1/ Rat IgG2a,k Mouse 555308 
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3.1.6  Magnetically labelled microbeads for cell separation 
 
Anti-mouse B220   Miltenyi Biotech (# 120-000-299), Bergisch Gladbach, 
DE 
Anti-mouse CD11b/Mac-1  Miltenyi Biotech (# 120-000-300), Bergisch Gladbach, 
DE 
Anti-mouse TER-119   Miltenyi Biotech (# 120-000-303), Bergisch Gladbach, 
DE 
Anti-mouse  Sca-1   Miltenyi Biotech (# 120-001-503), Bergisch Gladbach, 
DE 
 
3.1.7  Chemokines and cytokines 
 
basic FGF        TeBU-bio (# 10019-B), Offenbach, DE 
PDGF-BB        TeBU-bio (# 10014-B), Offenbach, DE 
rhFLT3-L        TeBU-bio (# 300-19), Offenbach, DE 
rhTPO         TeBU-bio (# 300-18), Offenbach, DE 
rmGM-CSF        R & D Systems (# 016315-03), Wiesbaden, DE 
rmIL-3 (E.coli)       R & D Systems (# 14190-094), Wiesbaden, DE 
rmIL-6      TeBU-bio  (#  216-16),  Offenbach,  DE 
rmSCF      Peprotech  (#  250-53),  Offenbach,  DE 
rmSDF-1α     R&D  Systems,  Wiesbaden,  DE 
rhTNF-1α        R&D Systems (# 410-MT), Wiesbaden, DE 
 
3.1.8 Buffers 
 
2 X SDS Gel-loading buffer 
Tris-Cl  pH  6.8     100  mM 
SDS (electrophoresis grade)   4% (w/v) 
Bromophenol  blue    0.2%  (w/v) 
Glycerol     20%  (v/v) 
Dithiothreitol 
(or) β-mercaptoethanol   200  mM 
Components were dissolved in dH2O 
Dithiothreitol or β-mercaptoethanol was added to the buffer just before use. 
 
GST-Fish buffer 
Tris-HCl pH 7.4      50mM 
NaCl      150mM 
MgCl2      4 m M  
Glycerol     10%  (v/v) 
Nonident  P-40     1%  (v/v) 
Components were dissolved in dH2O 
 
Isolation buffer for lineage
 depleted bone marrow cells:  
PBS + 0.5% BSA + 2 mM EDTA 
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Microinjection buffer 
KCl  pH  7.2     137  mM 
NaCl      2.7  mM 
Na2HPO4     8.1  mM 
KH2PO4     1.5  mM 
MgCl2      4  mM 
Components were dissolved in dH2O 
 
0.5M EDTA pH 8.0 
Dissolved in dH2O 
 
Tris Buffer Saline (TBS) pH 7.4 
NaCl      150  mM 
Tris-Cl      20  mM 
 
Tris-Glycine electrophoresis buffer 
Tris      25  mM 
Glycine       250  mM 
S D S       1 %   ( w / v )  
Components were dissolved in dH2O 
 
Tris-Cl  pH  6.8    1.0  M 
Dissolved in dH2O 
 
Tris-Cl  pH  8.8    1.5  M 
Dissolved in dH2O 
 
Tris-EDTA buffer (TE) pH 7.5  
Tris-Cl      100  mM 
EDTA      10  mM 
Components were dissolved in dH2O 
 
TE/dH20 buffer 
0.1  X  TE     2  parts 
dH20      1  part 
 
Salt solution 
K C l       1   M  
Glucose     20% 
Na2HPO4     141  mM 
Components were added to dH2O and volume made up to 50 ml. 
 
2X HBS solution 
HEPES       42  mM 
NaCl      171  mM 
Salt  solution     1  ml 
The volume was made to 85 ml with dH2O, pH of the solution was adjusted to 7.0, 7.05, 
7.10 respectively with NaOH, and the volume made up to 100 ml with dH2O. The solution 
was sterile filtered with 0.22 µm filter and stored at -20°C in aliquots until use. 
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2.5 M CaCl2 solution 
CaCl2      2 . 5   M  
The component was dissolved in dH2O and sterile filtered with 0.22 µm filter and stored at 
-20°C in aliquots until use. 
 
3.1.9  Instruments and apparatus 
 
2-well chamber slides      Nunc (# 177437), Rochester, NY 
4-well chamber slides      Nunc (# 177429), Rochester, NY 
48 well chemotaxis chamber   NeuroProbe, Gaithersburg, MD, USA 
Autoclave     Integra  Biosciences,  Baar,  CH 
Bacterial incubator       Heraeus, Hanau, DE 
Balance     Sartorius,  Göttingen,  DE 
Cell culture flasks      Greiner, Frickenhausen, DE 
Cell culture incubator     Heraeus, Hanau, DE 
Cell culture dishes      Greiner, Frickenhausen; Becton Dickinson, DE 
CELLocate glass cover slips with grids,  
- Grid size 55 µm       Eppendorf (# 5245952.004), Hamburg, DE 
Cell  scraper     Corning,  Wiesbaden,  DE 
Cell sieve (40 µm)       Becton Dickinson, Heidelberg, DE 
Centrifuge       Eppendorf,  Hamburg,  DE 
Cryotubes     Nalgene,  Rochester,  NY 
Electrophoresis apparatus 
- For agarose gels       Life Technologies, Karlsruhe, DE 
- For SDS-PAGE       Bio-Rad Laboratories, Munich, DE 
FACS tubes        Fisher Scientific ( # 352063), Schwerte, DE 
Femtotips II        Eppendorf (# 5242 957.000), Hamburg, DE 
Femtojet       Eppendorf,  Hamburg,  DE 
Flow chamber kit       
 - Circular parallel plate    GlycoTech, Maryland, U.S.A 
Flow-cytometer Coulter Epics II  Beckman Coulter, DE 
Hyperfilm  ECL   Amersham  Biosciences (# RPN3103K), Freiburg, DE 
Injectman NI 2       Eppendorf, Hamburg, DE 
Light microscope       Zeiss, Göttingen; Leica, Wetzlar, DE 
Nitrocellulose membrane (0.45 µm) Schleicher & Schuell (# 10401196), Dassel, DE 
MACS separation column  Miltenyi Biotech (# 130-041-306), Bergisch-Gladbach, 
DE 
MACS Pre-separation Filter    Miltenyi Biotec, Bergisch-Gladbach, DE 
Microscope Olympus CK-2;  
Zeiss Axiovert 135      Zeiss, Oberkochen, DE 
Microloader        Eppendorf (# 5242 956.003), Hamburg, DE 
Microtubes        Eppendorf, Hamburg; Sarstedt, Nümbrecht, DE 
Micropipette tips 
Micropipettes 
Mini MACS         Miltenyi Biotec, Bergisch-Gladbach, DE 
Perfusion pump       (Perfusor secura FT) Braun, Heidelberg, DE 
Perfusion syringe      Braun, Melsungen, DE 
Petridishes 
pH-Meter 
Polyallomer Centrifuge tubes    Beckman, Krefeld, DE 
PVP free, 8 µm pore size filters        NeuroProbe, Gaithersburg, MD, USA 
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PVDF membrane (0.2 µm)    Schleicher & Schuell, Dassel, DE 
Spectrophotometer     
Stericup-Filter     Millipore  (#  SCGPU05RE),  Eschborn,  DE 
Sterile  filter     Millipore,  Eschborn,  DE 
-0.22 µm        Millipore, Eschborn, DE  
-0.45  µm     Millipore,  Eschborn,  DE 
Table top centrifuge      Eppendorf, Hamburg, DE 
Thermomixer 5436      Eppendorf, Hamburg, DE 
Ultra-centrifuge      Beckman,  DE 
Ultrospec  II     Biochrom,  Cambridge,  GB 
Vario MACS         Miltenyi Biotec, Bergisch-Gladbach, DE 
Vortex      Eppendorf,  Hamburg,  DE 
Water bath        Julabo Labortechnik, Seelbach, DE 
Whatman-Paper       Schleicher & Schuell, Dassel, DE 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  333.0 MATERIALS AND METHODS 
 
3.1.10  cDNAs and plasmid vectors 
 
3.1.10.1  Plasmids used for production of Moloney type retroviral vectors 
 
Pinco 
 
Retroviral expression vector derived from Moloney murine Leukemia virus, length = 3506 
bp. 
 
 
 
 
Pinco Rho wild type 
 
Homo sapiens Ras homolog gene family member A (RHOA), length = 1926 bp, cloned 
into Pinco 5’ of an ATG and Myc-Tag sequence, was obtained from Dr. Martin Ruthardt, 
Hematology, J. W. Goethe-University, Frankfurt. 
 
Rho14V25N in Pinco 
 
Mutated Homo sapiens RhoA cDNA, length = 1926 bp, with G14V and F25N transitions 
which had been cloned into Pinco 5’ of an ATG and Myc-Tag sequence. 
 
Pinco RacV12 
 
Homo sapiens Ras-related C3 botulinum toxin substrate 1, Rho family, small GTP binding 
protein Rac1, length = 2355 bp, with G12V transitions which had been cloned into Pinco 5’ 
of an ATG and Myc-Tag sequence. 
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Pinco RacN17 
 
Homo sapiens Ras-related C3 botulinum toxin substrate 1, Rho family, small GTP binding 
protein Rac1, length = 2355 bp, with T17N transitions which had been cloned into Pinco 5’ 
of an ATG and Myc-Tag sequence. 
 
Pinco C3 (C3 transferase d.n. RhoA) 
 
C. limosum C3 gene, Length = 1022 bp, which had been cloned into Pinco 5’ of an ATG.  
 
All Moloney type retroviral vectors were kindly provided by Dr. Martin Ruthardt, 
Hematology, J. W. Goethe-University, Frankfurt. 
 
3.1.10.2  Plasmids used for production of lentiviral vectors 
 
SEW,  obtained from Dr. Manuel Grez, Georg Speyer Haus, Biomedical Research 
Institute, Frankfurt. 
 
SEW HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
WPRE GFP LTR
HIVDU3
ψ
 
 
SIEW,  obtained from Dr. Manuel Grez, Georg Speyer Haus, Biomedical Research 
Institute, Frankfurt. 
 
SIEW HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
WPRE eGFP LTR
HIVDU3
IRES
ψ
 
 
SIEW-RFA 
SIEW vector with the Gateway recombination sites inserted. 
 
 
SIEW-RFA
HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
LTR
HIVDU3
attR1c c d B WPRE eGFP IRES attR2
ψ
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SIEW-RFA-Rho V14 
 
Mutated Homo sapiens RhoA cDNA, length = 1926 bp, with G14V and F25N transitions 
which had been cloned into SIEW-RFA 5’ of an ATG. 
 
SIEW-RFA-C3 
 
C. limosum C3 gene, Length = 1022 bp, which had been cloned into SIEW-RFA 5’ of an 
ATG.  
 
SIEW-RFA-Rac V12 
 
Homo sapiens Ras-related C3 botulinum toxin substrate 1, Rho family, small GTP binding 
protein Rac1, length = 2355 bp, with G12V transitions which had been cloned into SIEW-
RFA 5’ of an ATG.  
 
SIEW-RFA-Rac N17 
 
Homo sapiens Ras-related C3 botulinum toxin substrate 1, Rho family, small GTP binding 
protein Rac1, length = 2355 bp, with T17N transitions which had been cloned into SIEW-
RFA 5’ of an ATG.  
 
All SIEW-RFA constructs were provided by Dr. B. Rüster, Stem Cell Biology, DRK-
Blutspendedienst, Frankfurt, Germany. 
 
3.1.10.3  Construction of SIEW-RFA 
Cloning of the Lentiviral SIEW-RFA vector
GFP replaced with IRES-GFP
GATEWAY
®recombination sites inserted
SEW HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
WPRE GFP LTR
HIVDU3
ψ
SIEW HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
WPRE eGFP LTR
HIVDU3
IRES
ψ
SIEW-RFA
HIV
U3/R/U5
RRE
SFFV-P cPPT/
CTS
LTR
HIVDU3
attR1c c d B WPRE eGFP IRES attR2
ψ
 
 
Fig.3.1 Construction of SIEW-RFA. Within the SEW vector, the GFP sequence was replaced by 
an IRES-GFP cassette. Subsequently, attR1 and attR2 recombination sites flanking a ccdB suicide 
sequence were inserted 5´of IRES-GFP. 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  363.0 MATERIALS AND METHODS 
 
Recombination of a mutant Rac gene into SIEW-RFA 
 
Recombination of Rho GTPase encoding cDNAs using Gateway
®-
Technology (Invitrogen)
attL1 gene of interest attL2
pENTR
LR-Clonase reaction
insertion of gene of interest (Rac1)
SIEW-RFA Rac1
RRE
SFFV-P
cPPT/
CTS
LTR
HIVDU3
attB1 WPRE eGFP IRES attB2 HIV
U3/R/U5
Rac1
ψ
SIEW-RFA
RRE
SFFV-P cPPT/
CTS
LTR
HIVDU3
attR1 ccdB WPRE eGFP IRES attR2 HIV
U3/R/U5
ψ
 
 
Fig.3.2 Recombination of a mutant Rac gene into SIEW-RFA. A cDNA encoding a mutated Rho 
GTPase, subcloned into the pENTR “Entry” vector is incubated with SIEW-RFA in a clonase 
reaction, yielding SIEW-RFA, e.g. RacV12. 
 
3.1.10.4  Vectors used for microinjection 
 
Pinco  
 
Cloning vector pCNS, complete sequence, length = 3506 bp. 
 
Pinco Rho14V25N  
 
Mutated Homo sapiens RhoA cDNA, length = 1926 bp, with G14V and F25N transitions 
which had been cloned into Pinco 5’ of an ATG and Myc-Tag sequence. 
 
Pinco RacV12 
 
Homo sapiens Ras-related C3 botulinum toxin substrate 1, Rho family, small GTP binding 
protein Rac1, length = 2355 bp, with G12V transitions which had been cloned into Pinco 5’ 
of an ATG and Myc-Tag sequence. 
 
Pinco C3 (C3 transferase d.n. RhoA) 
 
C. limosum C3 gene, Length = 1022 bp, which had been cloned into Pinco 5’ of an ATG.  
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3.1.10.5  Packaging vectors for lentivirus production 
 
 
pCMV∆R8.91 
 
 
 
pCMV∆R8.91 
 
Lentiviral packaging vector expressing lentiviral gag-pol under the control of CMV 
promoter was kindly provided by Dr. Manuel Grez, Georg Speyer Haus, Biomedical 
Research Institute, Frankfurt. 
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pMD.2.VSVG 
 
 
The lentiviral packaging vector expressing pseudotyped envelope was kindly provided by 
Dr. Manuel Grez, Georg Speyer Haus, Biomedical Research Institute, Frankfurt. 
 
3.1.10.6  Packaging vectors for retrovirus production 
 
M57 
 
gagpol
SV40pA
SV40P
ColE1
Amp
 
 
M57 was kindly provided by Dr. Manuel Grez, Georg Speyer Haus, Biomedical Research 
Institute, Frankfurt. M57, a retroviral packaging vector expressing retroviral gag-pol under 
the control of SV40 promoter was used to complement the gag-pol expressed by retroviral 
packaging cell line Phoenix (Amphotropic or Ecotropic) during lentiviral production.  
 
Abbreviations (for 3.1.10) 
 
attR    recombination  sites 
ccdB    cytotoxic  ccdB  suicide gene CMV      Immediate  early 
promoter of Cytomegalovirus 
cPPT/CTS    central polypurine tract/central termination sequence (from HIV-1) 
EGFP      Enhanced green fluorescent protein (Sequence from pIRES2- 
EGFP from Clontech; Wild type-Gene from Aequorea victoria: 
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Prasher et al., 1992) 
Gag      Group-specific antigen (from HIV-1) 
IRES       Internal ribosome entry site (Sequence from pIRES2-EGFP from 
Clontech; IRES from Encephalomyocarditis virus [ECMV]) 
LTR HIV.U3     Long terminal repeat from HIV-1 with Deletion in the U3-Sequence 
MCS      Multiple  cloning  site 
pA      polyadenylation  signal 
Pol      Polymerase  (from  HIV-1) 
Rev       Regulator of viral expression (from HIV-1) 
RRE       Rev-responsive element (from HIV-1) 
RSV       LTR of Rous-Sarcoma virus 
R/U5       R- and U5-Sequences from HIV-1-LTR 
SA    Splice  acceptor  site 
SD    Splice  donor  site 
SFFV      3'-LTR of Spleen Focus Forming Virus 
SV40      Simian virus type 40 
Tat       Transactivator (from HIV-1) 
VSV-G     G-Glycoprotein from Vesicular Somatitis Virus 
WPRE     Woodchuck hepatitis virus post transcriptional regulatory element 
ψ       Packaging signal (from HIV-1) 
 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  403.0 MATERIALS AND METHODS 
3.1.11 Cells 
 
3.1.11.1  FDCP mix cells clone A4 
 
The murine multipotent factor-dependent cells FDCP (Factor Dependent Cell-Paterson) 
mix cells have previously been established from long-term bone marrow cultures of BDF1 
mice; (Spooncer, et al 1984), (Spooncer, et al 1986); These cells were stably transfected 
with enhanced Green Fluorescent Protein (eGFP) cDNA driven by the EF-1α promoter 
using a neomycin resistance gene. The CMV promoter of the plasmid pEGFP-N1 
(Clontech Laboratories, Palo Alto, CA, USA) was deleted and replaced with the EF-1α 
promoter from the plasmid pEF-BOS (Goldman, et al 1996). FDCP mix cells were 
transfected by electroporation and selected with 0.7 mg/ml G418 (Gibco, Paisley, UK). 
These cells are dependent on IL-3; FDCP mix cells were maintained in a primitive state by 
culturing them in IMDM supplemented with 20% horse serum and 20 ng/ml IL-3. The cells 
were cultured at a cell density higher than 2x10
5 cells /ml. 
 
3.1.11.2  Murine primary lineage-depleted (lin
-) and Stem Cell Antigen-1 (Sca-1) 
enriched (lin
- Sca-1
+) bone marrow cells 
 
The mouse lin
-Sca1
+ cells were freshly isolated from the femurs of 6-12 week old female 
Black 6 (C57BL6) mice. Murine bone marrow cells were negatively selected for lineage 
markers (TER-119, CD11b, B-220, Gr-1), lin
-, and positively selected for stem cell antigen 
(Sca-1
+) by magnetic activated cell sorting. The isolation of lin
- Sca-1
+ cells is described in 
detail in 3.2.5.1. The cells were cultured at a density of 5x10
5 cells/ml  in DMEM low-
glucose (1 g/l) supplemented with 20% (v/v) Fetal Bovine Serum (FBS) containing rmSCF 
(100 ng/ml), rmIL-3 (20 ng/ml), rmIL-6 (20 ng/ml), rmFlt-3 ligand (20 ng/ml) and rhTPO (20 
ng/ml ) for up to 24 hours. 
 
3.1.11.3  Mesenchymal Stem Cells (MSC)  
 
MSC were isolated from bone marrow samples of patients undergoing hip surgery. The 
cells were separated by density gradient centrifugation and adherence selection. The 
detailed selection procedure is described in 3.2.5.2. The cells were flow cytometrically 
analysed for the expression of mesenchymal markers CD73 and CD105 and for absence 
of CD45. MSC were cultured in DMEM low-glucose (1 g/l) supplemented with 20% (v/v) 
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FBS, basic Fibroblast Growth factor (bFGF, 10 ng/ml) and were passaged 1:3 every 3 to 4 
days by trypsinization (described in 3.2.1). 
 
3.1.11.4  Human Umbilical Vein Endothelial Cells (HUVEC)  
 
HUVEC cells were procured from Cell Systems (Endothelial umbilical pool 500K). The 
deep frozen vial was thawed in a 37°C water bath rapidly and 1ml of pre-warmed EBM-2 
medium was added drop-wise every minute until the volume reached 10 ml. Cells were 
seeded in a tissue culture flask which was pre-coated for 10 minutes at room temperature 
with 0.1% gelatin. The ells were grown in EBM-2 medium. After reaching 90% confluence 
cells were passaged approximately every 3 days at 1:6 by trypsinization (described in 
3.2.1). The cells were used until passage 7 for the experiments. 
 
3.1.11.5  Murine Embryonic Endothelial Progenitor Cells (eEPC)  
 
Murine embryonic endothelial progenitor cells were a kind gift from Prof. Jens Gille, 
Dermatology, J. W. Goethe-University, Frankfurt. They have originally been isolated from 
mouse embryos at E7.5 to E7.8 of development (Hatzopoulos, et al 1998). The cells were 
grown on 0.1% gelatin coated tissue cultures flasks and passaged every 3-4 days by 
trypsinization (described in 3.2.1). The culture medium used was DMEM high-glucose 
(4.5g/l), supplemented with 10% (v/v) FBS, 1% (w/v) L-glutamine, non-essential amino 
acids and β-mercaptoethanol. 
 
3.1.11.6  Human 293T cells 
 
293T cells, originally called 293tsA1609ne (DuBridge, et al 1987) and derived from 293 
cells, a continuous human embryonic kidney cell line transformed by sheared Type 5 
Adenovirus E1a and carrying a temperature sensitive T antigen co-selected with neomycin 
DNA (ATCC Number CRL-1573), (Graham, et al 1977). The cells were grown in DMEM 
containing glucose (4.5 g/l) supplemented with 10% (v/v) FBS and 1% 
Penicillin/Streptomycin. The cells were passaged 1:10 every 3 to 4 days by trypsinization 
(described in 3.2.1).  
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3.1.11.7 Phoenix  cells 
 
Phoenix cells are second-generation retrovirus producer lines for the generation of helper 
free ecotropic and amphotropic retroviruses. The lines are based on the 293T cell line. 
The cell line was created by placing into 293T cells constructs capable of producing gag-
pol, and envelope protein for ecotropic and amphotropic retroviruses. IRES-CD8 surface 
marker cDNA is situated downstream of the reading frame of the gag-pol construct. Thus, 
CD8 expression is a direct reflection of intracellular gag-pol expression and the stability of 
the producer cell population's ability to produce gag-pol can be readily monitored by flow 
cytometry. For both the gag-pol and envelope constructs, Non-Moloney virus promoters 
were used to minimize recombination potential. Gag-pol was introduced with hygromycin 
as the co-selectable marker and the envelope proteins were introduced with diphtheria 
resistance as the co-selectable marker (Nolan) The cells were grown in DMEM high-
glucose (4.5 g/l) supplemented with 10% (v/v) FBS and passaged 1:10 every 3 to 4 days 
by trypsinization (described in 3.2.1).  
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3.2 Methods 
 
3.2.1  Trypsinization of adherent cells 
 
The culture medium was removed by aspiration and the cell sheet was washed with PBS. 
Two ml of 0.025% trypsin solution was added to the adherent cells. After incubating for 5-
10 minutes at 37°C, cells were observed under the microscope. The cell culture flask was 
tapped slightly on the sides to detach the cells. When the cells were detached, 5 ml of 
FBS was added to inhibit the trypsin action. The cells were washed by centrifugation at 
300 x g for 5 minutes and resuspended in the desired cell concentration for various 
assays or seeded at a reduced factor. 
 
3.2.2  Determination of protein concentration 
 
Protein concentrations were determined by Bradford-assay with Bio-Rad protein detection 
kit according to the manufacturer’s instruction and quantified with a spectrophotometer at 
595 nm. The standards for protein concentration were prepared with different 
concentrations of BSA (0.1 to 1 µg/ml). 
 
3.2.3  Fluorescent labelling of MSC 
 
MSC were labelled with the fluorescent dye PKH-26 for migration assays. The cell sheet 
was washed and trypsinized as described in 3.2.1. The cells were pelleted by 
centrifugation at 300 x g for 5 minutes. The supernatant was carefully removed and the 
cells were resuspended with 1 ml of Diluent C at a concentration of 10
7 cells/ml. 1 ml of 
PKH-26 stain (8 µl of PKH-26 + 1 ml Diluent C) was added to the cell suspension. The mix 
was incubated in the dark at room temperature for 5 minutes with gentle agitation. 2 ml of 
FBS was added and incubated for 1 minute at room temperature with gentle agitation. 
Equal volume of serum medium containing was added to the mix and the cells were 
pelleted at 300 x g for 5 minutes. The cells were washed twice with the complete medium 
(DMEM low-glucose (1 g/l) supplemented with 20% (v/v) FBS) by centrifugation. The cell 
pellet was resuspended at a concentration of 5x10
5 cells/ml.  
 
3.2.4  Labelling of cells with fluorochrome conjugated antibodies for flow 
cytometric analysis 
 
The adherent or suspension cells were pelleted by centrifugation at 300 x g for 5 minutes. 
The cells were washed with PBS by centrifugation at 300 x g for 5 minutes. The resulting 
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cell pellet was resuspended at a density of 1x10
7 to 1x10
8 cells/ml in ice-cold PBS 
supplemented with 0.5% BSA. 10 µl of fluorochrome conjugated antibodies (FITC, PE) 
were added to the cell suspension and incubated for 30 minutes on ice. The cells were 
washed by centrifugation and analysed in a flow cytometer. 
 
3.2.5  Cell Isolation methods 
 
3.2.5.1   Isolation of lin
- Sca-1
+ cells from mouse bone marrow 
 
The murine lin
-Sca1
+ cells were isolated from the femurs of 6-12 week old female Black 6 
(C12BL6) mice. The femurs and tibiae of the mice were collected and bone marrow was 
flushed with isolation buffer using a syringe with a 25 G needle. The resulting cell 
suspension was passed through a 40 µm nylon filter which had been pre-wetted with PBS 
to disaggregate any cell clumps. The cells were washed by addition of PBS and 
subsequent centrifugation at 300 x g for 10 minutes. The supernatant was removed and 
the cells were resuspended at a density of 10
7  cells per 90 µl in the isolation buffer 
(described under 3.1.8). The cell suspension was incubated with 10 µl each of magnetic 
labelled microbeads coupled to antibodies against TER-119, CD11b, B-220, and Gr-1 for 
10
7 cells for 30 minutes in the dark at 4°C. A 10-fold volume of isolation buffer was added 
to the cell suspension and cells were washed twice by centrifugation at 300 x g for 10 
minutes. The cells were resuspended with 1 ml of ice-cold isolation buffer. The lineage 
depletion column (LD column) was placed in the magnetic field (Mini MACS, Miltenyi 
Biotech) and prepared by rinsing twice with the isolation buffer. The cell suspension was 
added onto the column. The unlabelled cells that passed through the column were 
collected as lineage depleted cells and the column was washed twice with the isolation 
buffer. The lineage depleted cells were washed by centrifugation at 300 x g for 10 minutes 
and counted. Aliquots of cells were taken for flow cytometric analysis. If positive selection 
for Sca1
+ cells was performed, the remaining cells were resuspended in the isolation 
buffer at a density of 10
7 cells per 80 µl. 20 µl of magnetic labelled microbeads coupled to 
antibody against Sca-1 were added to the cells and incubated for 15 minutes at 4°C in 
dark. The positive selection column was prepared by placing in the magnetic field and 
rinsing twice with isolation buffer. The cell suspension was loaded onto the column and 
the column was washed twice with the buffer. The column was removed from the 
magnetic field and placed over a 5 ml polypropylene collection tube. Isolation buffer was 
added to the column and the magnetically labelled cells were flushed out immediately by 
application of pressure with the plunger provided with the column to enrich for Sca-1
+ 
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cells. The cells were counted using a Neubauer counting chamber and an aliquot was 
taken for flow cytometric analysis. Before further processing, the cells were washed by 
centrifugation and resuspended in the culture medium at a density of 5x10
5  cells/ml 
DMEM low-glucose (1 g/l) supplemented with 20% (v/v) Fetal Bovine Serum (FBS) 
containing rmSCF (100 ng/ml), rmIL-3 (20 ng/ml), rmIL-6 (20 ng/ml), rmFlt-3 ligand (20 
ng/ml) and rhTPO (20 ng/ml ) for up to 24 hours. 
 
The efficiency of separation was determined by staining aliquots of cells taken before and 
after separation by labelling with fluorochrome-conjugated antibodies (FITC or PE) against 
TER-119, CD11b, B-220, and Sca-1 for 30 minutes on ice in dark. The cells were washed 
by centrifugation at 300 x g for 10 minutes. The pellet was resuspended in PBS and 
analysed by flow cytometry. 
 
3.2.5.2   Isolation of human bone marrow MSC  
 
MSC were isolated from bone marrow samples of patients undergoing hip surgery after 
informed consent by a procedure approved by the local ethics committee. The bone 
marrow cells were suspended in IMDM supplemented with 500 U/ml Heparin. Within 24 
hours after the operation, cells were passed through a 100 µm nylon filter and washed 
with PBS by centrifugation at 400 x g for 5 minutes. Cells were subsequently separated by 
density gradient centrifugation at 300 x g for 20 minutes without brake by layering them on 
ficoll solution (ρ, 1.709 g/cm
3). The mononuclear interphase cells were collected carefully 
using a sterile pipette and washed twice with PBS by centrifugation at 300 x g for 5 
minutes. The pellet was resuspended in DMEM low-glucose (1 g/l) supplemented with 
20% (v/v) FBS and seeded at a density of 5x10
6 cells/ml into tissue culture containing 
bFGF (10 ng/ml). Cells were incubated at 37°C and 5% CO2. The medium was changed 
every 2-3 days. After three weeks, a layer of spindle-shaped cells had formed (MSC). 
These cells stained negative for CD45, and positive for the mesenchymal cell markers 
CD105 and CD73 using flow cytometric analysis. The cells were passaged by 
trypsinization and split regularly 1:3 before the cells reached confluence. Their 
pluripotency was confirmed by successful induction of osteoblastic, chondrogenic, and 
adipogenic differentiation upon addition of the respective media. MSC populations could 
be passaged 10 to 12 times, without the loss of their multipotentiality before their growth 
slowed or stopped. MSC were cultured in DMEM low-glucose (1 g/l) supplemented with 
20% (v/v) FBS, basic Fibroblast Growth factor (bFGF, 10 ng/ml). 
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3.2.6  Cell Migration Methods 
 
3.2.6.1   Boyden chamber type migration assay 
 
A  Boyden chamber type migration assay was performed to asses the transmigration 
potential of the cells. The system consists of two chambers, separated by a 
polycarbonate, polyvinylpyrrolidine-free membrane of a definite pore size through which 
the cells migrate. A membrane with 8 µm pore size was used to asses the migration of 
MSC whereas a 5 µm pore-sized membrane was used for HSC. The membrane was pre-
coated with fibronectin (1 µg/ml), laminin (100 ng/ml), vitronectin (100 ng/ml), or poly-L-
lysine (10 µg/ml) in sterile PBS for 2 hours at 37°C. The membranes were air-dried for few 
minutes before mounting in the chamber. The adherent cell types (e.g., MSC) were 
trypsinized, washed once with PBS, and resuspended at a density of 5x10
6 cells/ml in 
DMEM containing 0.5% (w/v) Bovine Serum Albumin (BSA), and if necessary the test 
substances were added to the cells suspensions. The cell suspension was incubated at 
37°C, 5% CO2 for 1 h in a 10 ml polypropylene tube in an upright position. The test 
substances were added to the lower wells of the chamber in 32 µl volume in pre-warmed 
medium. The pre-coated membrane was placed in-between the two chambers. The upper 
chamber was assembled and the system was screwed tight until the resistance to 
unscrew surmounted the effect of slightly pressured clockwise turning. The cells were 
seeded into the upper wells in a pre-warmed medium of DMEM containing 0.5% BSA 
containing 25,000 cells per well. 
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Fig 3.1 Pictorial representation of chemotaxis chamber (Modified Boyden migration chamber). 
+ represents the presence of chemoattractant, - represents the absence of chemoattractant. 
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Cells were allowed to migrate through the pores, across the thickness of the membrane, 
and towards the source of chemoattractant in the lower chamber (Fig 3.1). Cells that 
migrated across the membrane and attached to the underside were stained (adherent 
cells) and microscopically counted or analysed by flow cytometer. If non-adherent cells 
were used, they were collected from the lower chamber into tubes for flow cytometry. To 
the cells collected in tubes, a fixed number of unlabelled cells were added. Flow 
cytometric analysis was performed to determine the ratio between unlabelled and labelled 
cells in the migrated fraction. By comparison of this ratio to that of the input control, the 
number of migrated cells was quantified. 
 
Pre-coating of chemotaxis membrane 
 
The porous membrane (8 µm) used for migrated experiments in Boyden chamber type 
migration assay were pre-coated with extracellular matrix (ECM) substances. ECM 
substances were diluted in PBS and the membranes were coated on both the sides 
unless otherwise specified with ECM substances by passive adsorption for 2 hours at 
37°C or 4°C overnight. The membranes were washed once with PBS and air-dried before 
mounting in the chemotaxis chamber.  
 
May-Grünwald Giemsa staining of migrated cells on chemotaxis membrane 
 
The migrated cells on the chemotaxis membrane were visualized by May-Grünwald 
Giemsa’s staining. The migrated cells (MSC) after migration were found attached to the 
lower surface of the chemotaxis membrane. The migrated cells on the membrane were 
fixed with ice-cold methanol (100%) for 15 minutes, stained with May-Grünwald solution 
for 5 minutes. After a brief wash in the distilled water, the cells were stained with Giemsa’s 
solution (1:10 dilution of the stock) for 15 minutes, rinsed with distilled water briefly, 
visualized under the light microscope and documented. 
 
3.2.6.2   Chemokinesis Assay 
 
The non-directional random migration was determined by chemokinesis assay (Strobel, et 
al 1997). Adherent and non-adherent cells were used for chemokinesis assays. Ninety-six 
well plates for non-adherent cells and 8-chamber glass slides for adherent cells were 
used. The wells or the chambers were pre-coated with human fibronectin (10 µg/ml), 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  483.0 MATERIALS AND METHODS 
gelatin (0.1%), laminin (100 ng/ml), vitronectin (100 ng/ml), or poly-L-lysine (10 µg/ml) for 
2 hours at 37°C or at 4°C overnight. The coating medium was removed and the wells or 
chambers were washed briefly with PBS twice. 10,000 non-adherent cells or 25,000 
adherent cells were seeded per well/chamber in a 96-well plate or a 8-chamber slide. The 
plate or the chamber slide was positioned at an angle of elevation of 80° immediately after 
seeding at 37°C, 5% CO2 for 24 hours so that the cells could accumulate at the lower end 
of the well or the chamber. After adding the test substances, the plate or the slide was re-
positioned at an angle of 15°C for 24 hours. The distance to which the cells have migrated 
was documented by a colour photograph. Video microscopic imaging was performed of 
the cells kept at 15° inclined position each for 20 minutes, 1 hour or overnight at 200 x or 
400 x magnification. The test substances were added for certain experiments 2 hours 
before the video microscopic imaging. The microscopic table was pre-warmed to 37°C 
throughout the assay period. A box ventilated with an atmosphere with 5% CO2 in air was 
constructed to keep the pH constant during the observation periods. In some experiments, 
medium buffered with HEPES was also used. 
 
3.2.6.3   Transendothelial migration assay 
 
Transendothelial migration assay was performed to investigate the migration behaviour of 
progenitor cells through a layer of endothelial cells. The assay was performed with 
transwells of pore size 5 µm to asses HPC migration and 8 µm pore size membranes for 
MSC migration. HUVEC were seeded on gelatine (0.1%) coated transwells at 
concentration of 30,000 cells per well. The non-adherent cells were removed 24 hours 
after seeding the cells by medium flushing. The confluence and the membrane integrity of 
the endothelial cells were checked by measuring the permeability for fluorescein 
isothiocyanate (FITC)-dextran 3000. FITC-dextran 3000 was added to the upper chamber 
of the transwells, incubated at 37°C, 5% CO2 for 2 h. Aliquots of the medium were taken 
from the upper and the lower chamber of the transwells and the fluorescence is measured 
with a Enzyme Linked Immunosorbent Assay (ELISA) reader at a wavelength of 521 nm. 
The endothelial cells were used stimulated or unstimulated with rhTNF-1α for 2 hours at 
37°C. For some experiments, the endothelial cells were treated with toxins, inhibitors, or 
inducers before adding primary cells. Endothelial cells were washed twice with the assay 
medium before adding the primary cells in the upper compartment. Twenty-five thousand 
(25,000) cells per well in case of MSC (labelled with PKH-26) or 5x10
4 cells per well in 
case of HSC (GFP positive or fluorescent labelled) were added to the upper compartment  
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Fig 3.2 Pictorial representation of transendothelial migration of stem cells. + represents the 
presence of chemoattractant,  – represents the absence of chemoattractant. 
 
with 0.3 ml assay medium (DMEM containing 0.1% (w/v) BSA) with or without the test 
substances. 1 ml of the assay medium with or without the test substances was added to 
the lower compartment. The plate was incubated at 37°C, 5% CO2 for 6 hours. The cells 
that migrated to the lower compartment or the underside of the membrane (Fig 3.2) were 
collected in tubes or fixed, stained and counted. To the cells collected in tubes for flow-
cytometric analysis, a fixed number of unlabelled cells were added. Flow-cytometric 
analysis was used to determine the ratio between unlabelled and labelled cells in the 
migrated fraction. By comparison of this ratio to that of the input control, the number of 
migrated cells was quantified. 
 
3.2.6.4   Migration of cells under shear stress 
 
The migration of cells is an important step in homing of stem cells into the stem cell niche. 
The assays described so far were migration of cells in static conditions. But in in vivo 
conditions, the migration occurs in a condition of shear stress where the migrating or 
homing cells interact with the underlying endothelium and extravasate through the 
endothelial cell layer as described by Springer (Springer 1994). Flow chamber migrating 
assay was employed for this purpose.  
 
The apparatus (Fig 3.3) consists of a circular flow chamber with an inlet port through 
which the stem or progenitor cells were injected, an outlet port, where the flow out medium 
and cells pass through and a vacuum port which creates a vacuum. This apparatus was 
mounted on a glass slide coated with endothelial layer (HUVEC). The entire setup was 
placed on an inverted microscope connected to a video system to document the motility of 
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the cells. The tubing system was connected to the flow chamber ports by luer locks. The 
stem or progenitor cells were flushed into the chamber with a constant shear stress (0.1 
dyn/cm
2 to 4 dyn/cm
2) through a tubing system connected to an injection syringe which in 
turn is operated by a perfusion pump whose velocity could be modified manually (2.5 ml/hr 
to 99 ml/hr). The system creates a laminar flow of the liquid over the endothelial layer. The 
shear stress formed in the system was calculated using the formula: 
 
Shear stress = 6Qµ/bh
2 
Where, 
Q = flow rate (cm
3/s) 
µ = fluid viscosity (cp or dyn s/cm
2)  
h = channel height (254 µm for gasket used) 
b = channel width (5 mm for 0.010 mm gasket) 
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Fig 3.3 Pictorial representation of parallel plate flow chamber. 
 
The rolling and adhesion of the stem or progenitor cells over the endothelial layer was 
studied using this system. Initially, the stem or progenitor cells were flushed at a constant 
shear stress of 0.1 dyn/cm
2 (2.5 ml/h) at a rate of ~ 4x10
4 cells/min for 10 minutes over the 
endothelial layer. Representative pictures of three different fields were taken to asses the 
adhesion of cells in lower shear stress. A real time movie was made at this shear rate for 
10-20 seconds to asses the rolling of cells over the endothelium. The shear stress was 
increased to a rate of 2 dyn/cm
2 for 10 minutes where most of the progenitor cells bound 
lightly to the endothelium was flushed away and tightly bound cells remain.  
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3.2.7  Microinjection of Rho GTPase cDNA 
 
Microinjection is the physical introduction of DNA into the living cells. The Rho GTPase 
cDNAs RacV12 (activated Rac), RhoV14 (activated Rho), C3 transferase (C3 transferase 
from  C. botulinum) were subcloned into Pinco retroviral expression vector were 
microinjected into the nucleus of the cells using an Eppendorf InjectMan NI 2 and 
FemtoJet mounted to a Zeiss microscope Axiovert 135. As instrumental platform, an 
inverted microscope was fitted with a needle holder which can be moved at definite 
positions in x-, y- and z coordinates within the microscopic field is provided on a movable 
tray that takes up the culture vessel with the cells to be injected (Fig 3.4). CELLocate 
glass cover slips with microgrids grids for relocating the cells with grid size of 55 µm were 
coated by addition of human laminin (100 ng/ml) for 2 hours at 37°C or 4°C overnight 
incubation. The coating solution was removed; the cover slips were washed twice with 
PBS. MSC were seeded on the cover slips which were placed in a cell culture dish at a 
constant cell density so that the cells remained without contact to neighbouring cells. The 
cells were allowed to attach at 37°C, 5% CO2 for 24 hours. 
 
Microinjection needle
Cells in the culture dish
Inverted microscope table
Microinjection needle
Cells in the culture dish
Inverted microscope table
 
Fig 3.4 Microinjection of adherent cells. Adherent cells were seeded in a culture dish on the 
cover slips. Microinjection was performed using an inverted microscope. 
 
The cells were cultured in a buffered medium (DMEM containing glucose (1 g/l) 
supplemented with 20% (v/v) FBS containing 25 mm HEPES, pH 7.2) to maintain the pH 
during the prolonged exposure to ambient conditions during the microinjection process. 
The vectors to be microinjected were prepared by centrifuging the sample for 15 minutes 
at 2000 rpm to sediment the debris/aggregates.  
 
Cells to be microinjected were brought into focus of the microscope. 2-10 µl of the sample 
to be microinjected were loaded into the microinjection needles (Femtotips). The needle 
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was mounted into the needle holder and the tip of the needle was brought immediately 
into the medium to avoid drying and crystal formation at the tip of the needle. The 
instrument pressure was set to low. The Z limit was set for the cells, the needle was 
moved to the search position, and injection of cells was started. Z limit was set where the 
tip of the microinjection needle was focused on the centre of the cell and it made an 
invagination of 1 µm without piercing the cell. Once the Z limit was set, the needle was 
moved upwards manually above the cells. This plane, from which the various cells were 
injected, was the search plane. 40X magnification were used for microinjection of 
adherent cells. The microscopic table was pre-warmed if the microinjection procedure took 
more than 30 minutes (Fig 3.2). The cells were left in the incubator at 37°C between 30 
minutes to 24h after microinjection and were immunohistochemically analysed. 
 
3.2.8  Viral gene transfer methods 
 
3.2.8.1  Production of Lentiviral particles 
 
Plating of packaging cells 
293T cells were used for packaging of lentiviral particles. The cells were trypsinized, 
washed by centrifugation at 1600 rpm (450 x g) for 5 minutes at room temperature and 
plated 24 hours before transfection in cell culture dishes  at a density of 5x10
6 cells/10 cm
2 
in DMEM containing glucose (4.5 g/l) supplemented with 10% (v/v) FBS, Penicillin (25 
U/ml), Streptomycin (25 U/ml). 
 
Transfection of packaging cells 
The cells were transfected by the calcium-phosphate mediated method. Fresh medium 
was given to the cells 2 hours before transfection. Chloroquine was added at a 
concentration of 100 mM to the cells 5 minutes before adding the transfection reagent mix. 
The transfection reagent mix was prepared by adding 3.5 µg ENV plasmid (pMD2-VSV-
G), 6.5 µg Packaging plasmid (CMV∆R8.91), and 10 µg of plasmid containing the gene to 
be expressed (described in 3.1.10.2) together per 10 cm plate. The volume was made to 
450 µl with TE/dH2O buffer. 50 µl of 2.5 M CaCl2 was added finally. The precipitate was 
formed by the drop-wise addition of 2X HBS to the DNA-CaCl2 mix while bubbling. The 
mixture was let at room temperature for 3-5 minutes before adding to the cells. The 
precipitate was removed from the cells after 16 hours and fresh medium (RPMI 
supplemented with 10% (v/v) FBS) was added to the cells for viral collection.  
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Viral collection 
The virus was collected 24 hours and 48 hours after the medium change after the 
transfection. The medium with the virus (viral supernatant, VS) was filtered through a 0.22 
µm filter pre-wetted with PBS. The supernatant was stored in 1 ml aliquots at –80°C. After 
the viral collection, the packaging cells were trypsinized and flow cytometrically analysed 
for the transfection efficiency.  
 
Concentration of Lentiviral particles 
The viral particles (293T supernatant) were collected from the packaging cells 24 and 48 
hours after the medium change. The viral supernatant was centrifuged at 500 x g for 5 
minutes and filtered through a 0.22 µm pore filter (pre-wetted with PBS). The viral 
particles were concentrated by ultracentrifugation at 50,000 x g for 140 minutes at 4°C. 
The resulting supernatant was discarded and the pellet was resuspended in 200 µl of PBS 
containing 1% HSA or BSA. The pellet of concentrated virus from the first collection was 
stored at 4°C overnight and pooled with the concentrated virus on the following day. The 
pellets were resuspended in a small tube on a rotating wheel for 1h. The resulting 
concentrated virus was aliquoted, stored in -80°C, and titered after freezing. The 
concentrated virus was used for transducing the target cells. 
 
Viral titre determination 
293T cells were used for viral titre determination. 2x10
5 cells were seeded per well in a 24 
well plate. After 24 hours, the medium was removed and 500 µl of fresh medium 
containing 4 µg/ml of polybrene with various dilutions of the virus (1:10, 1:100, and 
1:1000) was added to the cells. The cells were incubated for 72 hours at 37°C, 5% CO2. 
Subsequently, the medium was removed, the cells washed with PBS and trypsinized as 
described in 3.2.1. The cells were collected into the tubes and washed by centrifugation at 
300 x g for 5 minutes. The supernatant was aspirated and the cells were analysed by flow 
cytometry for the number of GFP positive cells. The viral titre was determined using the 
formula: 
 
 
No. of cells seeded x 2 x GFP positive cells % x dilution factor  
               100 
The viral titre was expressed as transducing units per ml (TU/ml) 
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Transduction of the target cells 
 
a) Transduction of adherent cells 
The cells were plated in a 6 or 24 well plate 24 hours before transduction, 2x10
5 cells/well 
in 6 well plate or 5x10
4 cells/well in 24 well plate. The medium was removed and 1 ml of 
the fresh complete medium having 4 µg/ml polybrene and 1 ml of the viral supernatant or 
MOI ~ 2.0 -3.0 was added to the cells. The cells were centrifuged at 2500 rpm (1260 x g) 
at 32°C for 90 minutes. The plates were incubated at 37°C, 5% CO2 for 18 hours after 
centrifugation. The medium was removed, the cells were trypsinized, an aliquot was 
analysed by flow cytometry for the expression of reporter gene (eGFP) to quantify the 
transduction efficiency, and the rest of the cells were split and cultured.   
 
b) Transduction of non-adherent cells 
For the transduction of non-adherent cells, a non-tissue culture treated 24-well plate pre-
coated with human retronectin (50 µg/ml) in PBS for 1h at room temperature or 4°C 
overnight was used. The retronectin was removed and the wells were washed twice with 
PBS. The cells were seeded into the wells (2x10
5 cells/well) and the viral supernatant was 
added to the cells to be transduced at an MOI of ~ 1.0-2.0. For transduction of mouse 
bone marrow primary cells (lin
- Sca-1
+), cytokines (rmSCF, 50 ng/ml; rmIL-3, 20ng/ml; 
rmIL-6, 20 ng/ml) were added to the viral supernatant. Protamin sulfate was added to the 
cells during transduction at a final concentration of 4 µg/ml. The cells with the viral 
supernatant were centrifuged at 1260 x g for 90 minutes at 32°C. The plate was removed 
from the centrifuge and incubated overnight at 37°C, 5% CO2. The medium was removed 
and an aliquot of the cells was analysed by flow cytometry to quantify the transduction 
efficiency and the rest of the cells were split at a cell density of 2x10
5 cells /ml (for mouse 
bone marrow lin
- Sca-1
+ cells). 
 
3.2.8.2    Production of Moloney type retroviral particles 
 
The following viral packaging cell lines were used. Phoenix A for amphotropic packaging 
to infect human cells and Phoenix E for Ecotropic packaging to infect murine cells were 
kindly provided by Dr. Grez, Biomedical Research Institute, Goerg Speyer Haus, 
Frankfurt. Packaging cells were cultured in DMEM containing glucose (4.5 g/l) 
supplemented with 10% (v/v) FBS and purity checked for the expression of CD8 surface 
antigen for the expression of gag-pol and selected with hygromycin and clostridium toxin 
for 2 weeks every 6 months.  
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Production of amphotropic retroviral particles 
Phoenix A cells were used for the production of amphotropic viral particles. Cells were 
trypsinized and washed by centrifugation at 1600 rpm (450 x g), 5 minutes at room 
temperature and plated at a density of 1.5x10
6 cells per 10 cm
2 cell culture dishes, 24 
hours before transfection in DMEM with glucose (4.5 g/l) supplemented with 10% (v/v) 
FBS, Penicillin (25U/ml) and Streptomycin (25 U/ml). 
 
Transfection of packaging cells 
The cells were tansfected by calcium-phosphate mediated method. Fresh medium was 
added to the cells 2 hours before transfection. Chloroquine (100 mM) was given to the 
cells 5 minutes before adding the transfection reagent. The transfection reagent mix was 
prepared by adding 3 µg of M57 plasmid (gag-pol expression plasmid) and 8 µg of Gene 
transfer plasmid (3.1.10.1) together per 10 cm plate. The volume was made to 450 µl with 
TE/dH2O buffer. 50 µl of 2.5 M CaCl2 was added finally. The precipitate was formed by the 
drop-wise addition of 2X HBS to the DNA-CaCl2 mix while bubbling. The mixture was left 
at room temperature for 5-10 minutes before adding to the cells. The precipitate was 
removed form the cells after 16 hours and fresh medium (RPMI supplemented with 10% 
FBS) was added to the cells for viral collection.  
 
Viral collection 
The virus was collected 24 hours and 48 hours after the last medium change. The medium 
with the virus (viral supernatant, VS) was filtered through a 0.22 µm filter pre-wetted with 
PBS before filtration. The supernatant was used immediately or stored in 1ml aliquots in -
80°C. After the viral collection, the packaging cells were washed with PBS and trypsinized. 
The cells were washed by centrifugation at 1000 rpm for 5 minutes, resuspended in PBS 
and flow cytometrically analysed for transfection efficiency for the reporter gene 
expression (eGFP).  
 
Transduction of the target cells 
 
a) Transduction of adherent cells: 
The target cells were plated in 6 or 24 well plate 24 hours before transduction at 5x10
4 
cells/well in 24 well plates or 2x10
5 cells/well in 6 well plates. The medium was removed, 
1-2 ml of the fresh complete medium (EBM-2 for HUVEC; DMEM containing glucose (4.5 
g/l) supplemented with 10% (v/v) FBS for eEPC) having 4 µg/ml polybrene and 1-2 ml of 
the viral supernatant was added to the cells. The cells were centrifuged at 2500 rpm (1260 
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x g) at 32°C for 90 minutes. The plates were incubated at 37°C, 5% CO2 for 18 hours after 
centrifugation. The medium was removed, fresh viral supernatant added and the 
transduction was repeated like the first day and cells were incubated for 24h at 37°C, 5% 
CO2. The cells were trypsinized and an aliquot was analysed by flow cytometry for the 
expression of reporter gene (eGFP) to quantify the transduction efficiency and the rest of 
the cells were split and cultured.   
 
b) Transduction of non-adherent cells: 
For non-adherent cells, the cells were transduced in a non-tissue culture treated plate pre-
coated with human retronectin. For this, 24 well plates which consisted of non-tissue 
culture plate pre-coated with retronectin (50 µg/ml) in PBS for 1 hour at room temperature 
or 4°C overnight. The retronectin was removed and the wells were washed twice with 
PBS. The cells were seeded in to the wells (2x10
5 cells/well) and the viral supernatant 
was added to the cells. For transduction of mouse bone marrow primary cells (lin
- Sca-1
+), 
cytokines (rmSCF, 50 ng/ml; rmIL-3, 20ng/ml; rmIL-6, 20 ng/ml) were added to the viral 
supernatant. Protamin sulfate was added to the cells before transduction at a 
concentration of 4 µg/ml. The cells with the viral supernatant were centrifuged at 2500 rpm 
(1260 x g) for 90 minutes at 32°C. The plate was removed from the centrifuge and 
incubated overnight at 37°C, 5% CO2. A new non-tissue culture plastic type plate was pre-
coated with retronectin (as mentioned above). The cells which had undergone the first 
round of transduction were transferred to new retronectin coated plates and the 
transduction was repeated with the new viral supernatant like on the day 1. The cells were 
incubated for 24 hours at 37°C, 5% CO2. The medium was removed and an aliquot of the 
cells was analysed by flow cytometry to quantify the transduction efficiency and the rest 
were split at a cell density of 2x10
5 cells /ml (for mouse bone marrow lin
- Sca-1
+ cells). 
When the transduction efficiency was found to be less than 50%, the transduced cells 
were flow cytometrically sorted for reporter gene expression (eGFP) to yield a 
homogenous population of infected cells. 
 
3.2.9  RNA extraction for Microarray analysis 
 
The medium was aspirated from the cells and the cell sheet was washed twice with ice-
cold PBS. 1ml of TRIzol reagent (Invitrogen) was added to the cells and the cells were 
scrapped into a clean nuclease free microcentrifuge tube, and incubated for 5 minutes at 
room temperature. 250 µl of chloroform was added; the mixture was vortexed for 15 
seconds and incubated at room temperature for 2-3 minutes. The cells were then 
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centrifuged at 11, 400 rpm (9000 x g) for 15 minutes at 4°C. The upper aqueous phase 
was transferred to a new microcentrifuge tube, mixed with an equal volume of 
isopropanol, and incubated overnight at –20°C or 10 minutes at room temperature. The 
mix was centrifuged at 9000 x g, 4°C for 10 minutes. The supernatant was discarded and 
the pellet was washed with 1 ml of 75% ethanol by centrifugation at 9000 x g for 5 minutes 
at 4°C. The supernatant was discarded; pellet air-dried and resuspended in 20 µl RNase 
free DEPC-water. The pellet was incubated at 55°C for 10 minutes with gentle agitation to 
enhance the dissolving of the pellet. The RNA was analysed on 1% agarose gel or the 
sample was frozen at –80°C until use. 
 
3.2.10 Oligonucleotide  Microarray 
 
Oligonucleotide microarray analysis to determine the modulation of gene expression in 
Rho GTPase modified cells were carried out in collaboration with Dr. Elena Puccetti, 
Hematology, Johann Wolfgang Goethe University, Frankfurt, Germany.  
 
RNA (8 µg) from the transduced cells were reverse transcribed to generate biotinylated 
complementary RNA (cRNA). The fragmented cRNA were hybridised to a murine Genome 
microarray (Affymetrix). The fluorescence intensity was normalized for the entire 
microarray. Data analysis was performed using Genespring Software (Silicon Genetics, 
San Carlos, CA). Genes which were either up or down regulated at least 2-fold in each 
case were selected.  
 
3.2.11  Pull down assays for Rho GTPases 
 
Pull down assays for Rho GTPases was performed using a kit obtained from Pierce 
Biotechnology. Adherent cells were cultured to confluence in a 10 cm cell culture dish or 
1x10
7 non-adherent cells were put on fibronectin (1 µg/ml) coated plates for 2 hours 
before the assay. The cells were treated with or without Rho GTPase inhibitor toxins or 
inducers for 2 hours at 37°C, 5% CO2 before the assay. Cells transduced with 
constitutively active Rac (RacV12), constitutively active Rho (RhoV14), dominant negative 
Rac (RacN17) or dominant negative Rho (RhoN17) were also used for the pull down 
assay.  
 
For adherent cells: 
The cell sheet was washed with ice-cold TBS. 0.5-1 ml of the lysis or wash buffer (Pierce) 
with the protease inhibitors was added to the cells and the cells were scraped off into a 
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clean microcentrifuge tube. The cells were vortexed briefly and incubated on ice for 5 
minutes. The cells were centrifuged at 16,000 x g for 15 minutes at 4°C. The supernatant 
was transferred to another clean microcentrifuge tube. 
 
For non-adherent cells: 
The cells were centrifuged at 100 x g for 5 minutes. The medium was removed and the 
cells were washed with 10ml of ice-cold TBS by centrifugation at 100 x g for minutes. The 
TBS was removed and the cells were resuspended with 0.5-1 ml of the lysis/wash buffer 
and vortexed briefly and incubated on ice for 5 minutes. The cells were centrifuged at 
16,000 x g for 15 minutes at 4°C. The supernatant was transferred to another clean 
microcentrifuge tube. 
 
In vitro GTPγS or GDP treatment  
 
The GTPγS or GDP treatment was done to ensure the proper working of the assay. 10 µl 
of 0.5 M EDTA, pH 8.0 (for a final concentration of 10 mM) was added to 500 µl of cell 
lysate. For a positive control, 5 µl of 10 mM GTPγS (for a final concentration of 0.1 mM) 
and for negative control 5 µl of 100 mM GDP (for a final concentration of 1 mM) were 
added. The mixture was incubated at 30°C for 30 minutes with constant agitation. The 
reaction was terminated by placing the sample on ice and adding 32 µl of 1 M MgCl2 (for a 
final concentration of 60 mM). 
 
Affinity precipitation of activated Rho GTPases 
One Swell Gel Immobilized Glutathione Disc was placed into a spin cup with a collection 
tube. 20 µg of GST-Pak1-PBD (for Rac1 and Cdc42) or 400 µg of GST-Rhotekin-RBD (for 
Rho A) was added to the spin column. 700 µl of the lysate was immediately transferred to 
the spin column. The cap of the collection tube was sealed with Parafilm to prevent 
leakage due to the high concentration of the detergent. The reaction mixture was 
incubated at 4°C for 1 hour with gentle rocking. The spin column was centrifuged with 
collection tube at 7,200 x g for 2 minutes. 400 µl of Lysis/Binding/Wash Buffer was added 
to the resin and centrifuged at 7,200 x g for 2 minutes and the procedure was repeated 
twice. 50 µl of 2X SDS sample buffer containing 1 part β-mercaptoethanol to 20 parts of 
the sample buffer was added to the resin. The samples were boiled at 95-100°C for 5 
minutes. The tubes were centrifuged at 7,200 x g for 2 minutes. Samples were 
electrophoresed on a 12% polyacrylamide gel or stored at -20°C for future use. 
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3.2.12  Western Blot analysis 
 
The proteins were resolved by 12%-15% SDS-PAGE and transferred to nitrocellulose 
membrane. The membrane was blocked by incubating in TBS containing 3% (w/v) BSA at 
room temperature for 2 hours with constant agitation. The membrane was rinsed with 
TBST (TBS containing 0.05% Tween-20). Transferred samples were incubated in TBS + 
3% Non fat dry milk + 1% sodium-azide containing anti-Rac1 antibody (1 µg/ml) or anti-
Rho antibody (1 µg/ml) solution at 4°C overnight. The membrane was washed five times 
for 5 minutes per wash with TBST. The membrane was incubated in the secondary 
antibody (anti-mouse IgG-HRP-conjugate) 1:5000 dilution at room temperature for 30 
minutes to 1 hour. The membrane was washed five times for 5 minutes per wash with 
TBST. The immunoblotted proteins were visualized with the enhanced chemiluminescent 
reagents (LumiGLO chemiluminescent substrate, Upstate, or ECL western blot detection 
reagents, Amersham Biosciences). The bands were developed on X-ray films for various 
time points. 
 
3.2.13 Immunofluorescent  staining 
 
Chamber slides were coated with 0.1% gelatin (w/v) or poly-L-lysine (10 µg/ml) or human 
fibronectin (1 µg/ml) for 2 hours at 37°C. The coating solution was removed and the 
chambers were washed twice with PBS. Cells were grown on the coated slides or cover 
slips at 37°C, 5% CO2. The cells were pre-treated with or without the inhibitors and 
inducers at 37°C for various time points. The medium was removed and the cells sheet 
was washed thrice briefly with PBS. The cells were fixed at room temperature with 4% 
paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton X-100 in PBS for 15 
minutes, and incubated with blocking solution (3% (w/v) non-fat dry milk in PBS) 
containing 0.1% (v/v) Triton X-100 for 1 hour at room temperature. The cells were 
immunostained with the primary antibody in PBS containing 3% (w/v) non-fat dry milk for 1 
hour at room temperature, washed thrice for 5 minutes per wash. The cells were 
incubated with phalloidin-FITC labeled and or fluorescent-labeled secondary antibody for 
1 hour at room temperature. The cells were washed 5 times for 5 minutes per wash with 
PBS. The chambers of the chamber slide were removed, were mounted with fluorescence 
protective mounting medium, and observed under the microscope. 
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3.2.14 Molecular  Biology  methods 
 
3.2.14.1 Bacterial  transformation 
 
One vial of 0.5M β-mercaptoethanol (ME), a frozen vial of top 10 competent cells was 
thawed on ice. The S. O. C medium was brought to room temperature. 2 µl of 0.5 M β-ME 
was pipetted into the vial of the competent cells and mixed by stirring gently with the 
pipette tip. Pipetting up and down was avoided. 10 µl of the vector was pipetted directly 
into the competent cells and mixed by stirring with the pipette tip and not by pipetting up 
and down. The vial was incubated on ice for 30 minutes. Water-bath or a thermo shaker 
was pre-warmed to 42°C. Heat shock was given for exactly 50 seconds at 42°C. The vial 
was removed from 42°C without shaking or mixing and placed on ice for 2 minutes. 250 ml 
of the S. O. C medium (at room temperature) was added to the tube. The vial with the 
transformed cells was shaken horizontally at 37°C for 1 hour at 225 rpm in a rotary shaker 
incubator. The vial was placed on ice. 2.5 µl of ampicillin (50 mg/ml stock) was given to 
the cells. 50 µl of the transformed cells was spread on a LB agar ampicillin plate. The 
plate was incubated for 8 hours at 37°C. Individual colonies were picked and inoculated in 
5 ml LB broth. The tubes were incubated overnight at 37°C, 225 rpm in a shaker (starter 
culture). The starter culture was inoculated into the 200 ml maxi culture (LB broth with 50 
µg/ml ampicillin) and incubated at 37°C, 225 rpm overnight.  
 
3.2.14.2 Maxi  preparation 
 
Maxi preparation of the plasmids was performed with Jet Star Plasmid Maxi preparation kit 
(Genomed) according to the manufacture’s instructions. The protocol for plasmid 
extraction includes that the expanded transformed cells were lysed by alkaline lysis and 
purified in an anion exchange resin columns (Genomed). 
 
3.2.15 Data  Analysis 
 
Results were expressed as Means +SD. Statistical analysis was carried out with Student’s 
t-test using Microsoft Excel (Microsoft Corporation, Redmond, WA). 
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4.0 RESULTS 
 
4.1  Role of Rho GTPase activation in migration of HPC  
 
4.1.1  Influence of SDF-1α on chemotactic migration of HPC 
 
Migration is an important step in homing of HPC into the stem cell niche after 
transplantation and is mediated by adhesion molecules and chemokines (Verfaillie, et al 
1994, Yang, et al 2001). SDF-1α has been descried as the most potent inducer of 
chemotaxis in HPC and also many other cell types circulating in the blood (Aiuti, et al 
1997). As HPC, either the murine multipotent progenitor cells FDCP mix or freshly isolated 
primary bone marrow cells enriched for primitive progenitors were used. Both chemotactic 
and chemokinetic migration were investigated. The optimal concentration of SDF-1α for 
the transmigration of FDCP mix HPC under experimental conditions was identified by 
dose response studies. The highest percentage of HPC migration was observed at 
concentrations from 30 to 100 ng/ml and at higher concentration reduced migration was 
observed (300 ng/ml; Fig. 4.1 A).  
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Fig. 4.1 Dose response curve of SDF-1α induced migration of FDCP mix cells. (A) 
Transmigration of FDCP mix cells across 5 µm pore membranes in a 48 well Boyden chamber type 
assay towards various concentrations of SDF-1α (0.3 to 300 ng/ml) was determined after 4 hours. 
Results are expressed as percentage of migrated cells (Means ± SD, n= 3-4). (B) Transmigration of 
FDCP mix cells across endothelial cell layers (HUVEC) seeded on 5 µm pore membrane in the 
transwell system towards various concentrations of SDF-1α (3.3 to 300 ng/ml) was determined 
after 4 hours. Results are expressed as percentage of migrated cells (means ± SD, n= 3). 
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The transmigration response of HPC to SDF-1α was similar when they were allowed to 
migrate across an endothelial cell layer (HUVEC). The migration response was dependent 
on the SDF-1α dose, and the percentage of migrated cells increased over the entire dose 
range investigated (Fig. 4.1 B). Since the dose response curve of SDF-1α induced 
migration of FDCP mix cells were similar to that of published results with primary bone 
marrow progenitor cells (lin
-Sca1
+ cells, see Fig. 4.3), FDCP mix cells were used as an 
alternate and analogous to HPC in experimental settings.   
 
4.1.2 Rho GTPase modulating bacterial toxins and phospholipids regulate 
chemotactic migration of HPC 
 
Since Rho GTPases were reported to regulate the migration of neutrophils (Gardiner, et al 
2002, Roberts, et al 1999), it was of interest to examine their involvement in chemotactic 
migration of HPC towards SDF-1α. HPC were treated with phospholipids and bacterial 
toxins that target Rho GTPases, and were allowed to migrate in a Boyden chamber type 
assay.  
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Fig 4.2 Influence of lysophospholipids (A) or pre-treatment with bacterial toxins (B) on SDF-
1α induced migration of FDCP mix HPC. Cells were pre-treated with LPA (25 µM), S1P (10 µM), 
Toxin B (100 ng/ml), LT (100 ng/ml), C2I-C3 (1000 ng/ml) for 2 hours at 37°C, 5% CO2. The 
phospholipids treatment (LPA, S1P in A) and the toxins treatment (Toxin B, LT, C2I-C3 in B) were 
performed in independent experiments. Transmigration of FDCP mix HPC across 5 µm pore 
membrane in a 48 well Boyden chamber type assay towards SDF-1α (100 ng/ml) was determined 
after 6 hours. Results are expressed as percentage of migrated cells (Means ± SD, n= 4). 
Statistical significance between the groups are represented by asterisks ** p<0.0002 *** p<0.0001. 
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Cells were pre-treated with the experimental substances Lysophosphatidic acid (LPA), 
Sphingosine-1-phosphate (S1P), Lethal Toxin (LT), Toxin B and C2I-C3 toxin. Pre-
treatment with LPA significantly inhibited SDF-1α induced transmigration whereas S1P 
pre-treatment did not affect the migration rate (Fig. 4.2 A).Toxin B, an inhibitor of Rho, Rac 
and Cdc42 and LT which inhibits Rac and Cdc42 were found to inhibit HPC migration 
whereas C2I-C3, a cell-permeable fusion toxin which specifically inactivates Rho but not 
Rac or Cdc42 did not affect HPC migration (Fig. 4.2 B).  
 
4.1.3  Influence of Rho GTPase modulating bacterial toxins on chemokinetic 
migration of HPC 
 
In order to analyse the role of Rho GTPases in chemokinetic (random) migration of HPC, 
lin
-Sca1
+ HPC enriched from mouse bone marrow were treated with Rho GTPase 
inhibiting toxins and their ability to migrate was assessed by a chemokinetic migration 
assay on fibronectin. The cells were seeded on a cell culture plate and treated with Rho 
inhibiting toxins, either C2I-C3, or Toxin B or LT. The migration of the cells was random 
rather than directional. The migration of the cells was observed under a microscope and 
recorded using time-lapse video microscopy. Both the migration speed and distance of 
migration were calculated. Interestingly, the cells treated with C2I-C3 were found to 
increase both the maximum number of migrating cells and the migrated distance 
compared to the control cells. However, pre-treatment with Toxin B and LT inhibited the 
majority of random migration (Fig. 4.3 A and B). 
 
To investigate in more detail the increase in the chemotactic migration of HPC after 
treatment with Rho inhibiting substances, time course experiments were performed. The 
effect of C2I-C3 was found to be time dependent, with the peak effect after ~2-3 hours, 
and declines to basal levels after 14-24 hours (Fig. 4.3 C and D). Taken together, the 
three different bacterial toxins which target the Rho GTPases showed distinct modulatory 
effects on the migration capacity of HPC. This implies that Rho GTPases control the 
chemokinetic migration behaviour in a similar way as the chemotactic migration of HPC 
towards SDF-1α. 
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Fig. 4.3 Effect of Rho GTPase modulating toxins on 
HPC migration. Chemokinetic migration of HPC treated 
with C2I-C3 (1 µg/ml), Toxin B (100 ng/ml) and LT (100 
ng/ml) was performed on fibronectin (10 µg/ml) pre-coated 
cell culture plates. The cells were pre-treated with toxins for 
2 hours at 37°C, 5%CO2. Results are expressed as 
percentage of migrated cells (Means ± SD, n= 7-18). (A) 
Percentage of cells migrated in the 20 min observation 
period. Results are expressed as percentage of migrated 
cells (B) Distance covered by pre-treated migrating cells in 
20 min observation period. The results are represented as 
means ± SD, n= 7-18. (C) Migration distance covered by 
HPC pre-treated with C2I-C3 (1 µg/ml) for various time 
points. (D) Percentage of migration of HPC pre-treated with 
C2I-C3 (1 µg/ml) for various time points. Results are 
expressed as percentage of migrated cells (Means ± SD, n=6-22). (E) Representative picture 
showing the chemokinetic migration assay. The cells were tracked for the migration from the 
beginning until the end of the observation period (20 minutes) and the migration distance was 
calculated. Statistical significance between the groups are represented by asterisks * p<0.03, *** 
p<0.0001. 
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4.2  Role of Rho GTPase activation in migration of embryonic endothelial 
progenitor cells (eEPC) 
 
4.2.1  Transduction of eEPC 
 
Embryonic endothelial progenitors (eEPC) have been reported to be a sub population of 
bone marrow derived progenitor cells, which take part in vascularization process. eEPC 
grow as an adherent cell population and are accessible to retroviral gene transduction. To 
study the role of Rho GTPases in eEPC, the endothelial progenitor cell population was 
stably transduced with Rac cDNA isoforms using a pseudotyped Moloney-type Retrovirus. 
The cells were subjected to two sequential transductions 24 hour apart as described in 
3.2.8.2 and the transduction efficiency was determined by flow cytometry for GFP 
expression. The eEPC were found to be highly transducible with retrovirus resulting in 
transduction efficiency from 80 to 95% 48 hours after the second round of transduction 
(Fig. 4.4 A and B).  
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Fig 4.4 Transduction of eEPC with retroviral expression vectors. (A and B) eEPC transduced 
with the indicated Rac cDNA isoforms or control vector were analysed for their transduction 
efficiency by detection of green fluorescence using flow cytometry. Values in A are means ± SD, 
n=3. (C) Microscopic pictures of transduced eEPC expressing mutant Rac tagged with GFP 
expression. Left panel in C represents Phase contrast pictures and right panel represents 
fluorescent microscopic pictures of transduced eEPC expressing mutant Rac with the reporter gene 
eGFP. Magnification 10 x.   
 
4.2.2  Morphology of transduced eEPC 
 
The morphological changes brought about by the expression of Rho GTPases in the 
eEPC were determined by retroviral transduction of eEPC with isoforms of Rho GTPase 
cDNAs. eEPC were subjected to two sequential transductions 24 hours apart with 
pseudotyped oncoretrovirus. The control vector transduced cells showed the normal 
angular morphology (Fig. 4.5 A). The expression of constitutively active Rac (RacV12) led 
to the formation of numerous lamellipodia like structures on the cell surfaces (Fig. 4.5 B) in 
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eEPC. In contrast, inhibition of Rac resulted in cells having an elongated morphology (Fig. 
4.5 C). 
ABC ABC
 
Fig. 4.5 Morphology of transduced eEPC Retrovirally transduced eEPC expressing the mutant 
Rac (c.a. and d.n.) upstream of reporter gene eGFP. Fluorescent microscopic pictures showing (A) 
control vector transduced (B) constitutively active Rac (RacV12) transduced (C) dominant negative 
Rac (RacN17) eEPC. Magnification 40 x. 
 
4.2.3  Flow cytometric characterization of Rac GTPase modified eEPC 
 
It was of interest to study the change in the surface receptor expression in eEPC after 
transduction with the mutant Rac cDNAs, RacV12 (c.a.) and RacN17 (d.n.) which induced 
a significant change in morphology of the cells. The transduced cells were analysed for 
the expression of adhesion molecules involved in homing processes, leukocyte specific 
marker (CD45), and endothelial cell markers Tie-2 and Flk-1. Flow cytometric analysis of 
transduced eEPC showed an increase in CD44 expression when dominant negative Rac 
is overexpressed or in Rac inactivated cells. There was also a slight rise in the surface 
expression of Tie-2 in Rac inactivated eEPC (Table. 4.1). Other receptors tested did not 
show any change in expression under activated or inactivated Rac conditions in eEPC. 
 
  Control RacV12 RacN17 
CD44  25 43 52 
CD49e  0.7 0.4 0.6 
Tie-2  74 76 90 
CD11b   0.3 0.3 0.3 
CD49d α4  0.2 0.3 0.8 
E-selectin  0.7 0.3 0.2 
L-selectin  0.2 0.3 0.4 
Flk-1  0.2 0.1 0.2 
CD45  0.2 0.1 0.1 
ICAM-1  0.7 0.3 0.3 
 
Table 4.1 Surface molecule expression of Rac modulated eEPC. The table shows the 
percentage of cells stained positive for cell surface molecules in eEPC after retroviral transduction 
with constitutively active Rac (RacV12) or dominant negative Rac (RacN17) and analysed by flow 
cytometry. Result of a representative experiment is shown here.  
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4.2.4  Adhesion of Rac modified eEPC to HUVEC under shear stress conditions 
 
The morphological changes and the change in cells surface molecule expression in eEPC 
observed after Rac modulation indicates that it might alter the adhesion behaviour of the 
cells on the endothelial layer. Moreover, the static migration assay conditions do not 
always reflect the physiological situation with flow, as it occurs in in vivo. In order to 
determine the function of Rac in shear stress conditions, eEPC were checked for their 
adhesion efficiency in an in vitro model simulating the flow conditions in a flow chamber 
assay on HUVEC. The adherent eEPC were trypsinized and were incubated for one hour 
at 37°C for recovery and stabilization of the surface markers. Cells were flushed with a 
shear rate of 0.1 dyn or 2 dyn/cm
2 for a definite time points over an endothelial cell 
monolayer (HUVEC). The difference in the adherence of the Rac modulated eEPC over 
the HUVEC layer was analysed. Under Rac inactivated conditions, eEPC adhered better 
both with, without TNF-α stimulation on HUVEC compared to respective controls, and 
regardless of the shear stress applied (Fig. 4.6).  
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Fig. 4.6 Adhesion of Rac modified eEPC under shear stress conditions. eEPC transduced with 
Rac isoforms (RacV12, c.a., RacN17, d.n.) were analysed for their adhesion on HUVEC under 
shear stress conditions in a flow chamber assay. HUVEC were used stimulated without or with 
TNF-α for 4 hours. The shear stress applied during the assay was 0.1 and 2 dyn/cm
2. The 
adhesion was measured after 10 minutes of flushing the eEPC over HUVEC at the mentioned 
shear stress. Values are means + SD, n=3-6. Statistical significance between the groups are 
represented by asterisks * p<0.05, ** p<0.002, *** p<0.0001. 
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4.3  Role of Rho GTPase activation in migration of MSC 
 
4.3.1  Migration induction by plasma and SDF-1α in HPC and MSC 
 
MSC have been reported to be important candidates for allogeneic bone marrow 
transplantation because of their potential to induce immunological tolerance. The basic 
mechanism involved in stem cell engraftment is the migration of the cells towards the 
chemotactic substances produced in the bone marrow.  
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Fig 4.7 Migration induction by plasma and SDF-1α in HPC and MSC. The transmigration of 
MSC and HPC towards various concentrations of SDF-1α (0.1 to 100 ng/ml; A, B) and human 
plasma (0.1 to 100%; C, D) across a porous membrane (5 µm pore size for HPC, 8 µm pore size 
for MSC) was determined in Boyden chamber type migration assay after 4 hours. Results are 
expressed as means + SD, n=6. 
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However, since no strong chemotactic agent has been reported yet for migration of MSC, 
the MSC migration towards SDF-1α, a strong chemoattractant reported for HPC (Aiuti, et 
al 1997) was determined. While more than 20% of the seeded HPC migrated towards 
SDF-1α (Fig. 4.7 B) there was no detectable migration obtained for MSC (Fig. 4.7 A). In 
search for a chemotactic agent, human plasma was used to investigate MSC migration. 
Human plasma was diluted and used as a chemotactic agent in Boyden chamber type 
assay. MSC were seeded in upper wells of the Boyden type chamber and plasma added 
to the lower wells. Interestingly, MSC responded to the plasma induced stimuli (Fig. 4.7 C) 
migrated towards the plasma source as detected by their migration to the lower side of the 
membrane. The percentage of MSC induced to migrate towards plasma was similar to 
that obtained for HPC (Fig. 4.7 C and D). 
 
4.3.2  Optimization of experimental conditions for MSC migration in transwell 
systems 
 
The migration of MSC has not yet been thoroughly investigated. Especially, in vitro 
analysis of transwell migration behaviour of MSC is poorly characterized although in vitro 
migration assays like Boyden chamber type migration assays have found general 
acceptance for the study of chemotactic migration of HPC. However, the conditions for 
such migration for MSC are different from HPC since MSC grow as adherent cells in vitro 
unlike HPC.  
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After migration assay period, cells on the 
membrane were fixed with methanol and 
then non-migrated cells on the upper 
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Membrane wiping
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and enumerated in situ using a 
microscope
Analysis
Shining side facing upwards and non-
shining side facing downwards in the 
chemotaxis chamber
Membrane orientation
VARIATIONS TESTED PARAMETER
 
Table 4.2 Experimental conditions for migration of MSC in a 48-well Boyden chamber type 
migration assay. Methods were standardized for the pre-incubation, membrane pre-coating with 
ECM substances, membrane orientation, and fixation of cells on the membrane. 
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Therefore, the conditions required to qualitatively and quantitatively visualize and 
 
ig. 4.8 Microscopic image of the membrane after MSC migration focussed on the upper and 
ependence of MSC transwell migration on plasma concentration 
ince the MSC showed a chemotactic migratory response towards human plasma (Fig. 
enumerate the migration of MSC were standardized. A summary of these findings is given 
in Table 4.2. The MSC migrated through the pores of the membrane and found attached 
to the lower side were enumerated microscopically as shown in Fig. 4.8. 
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upper side
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*
upper side
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F
lower side. Asterisks represent the migrated cells present on the lower side of the membrane and 
arrows indicate the pores on the upper surface of the membrane.  
 
D
 
S
4.9), it was used as a chemotactic agent in this study. The concentration of human plasma 
to be used for migration experiments was optimized by dose response studies. MSC 
showed an optimal migration percentage between 0.5 to 1% human plasma as shown in 
Fig. 4.9 B. Increasing plasma concentrations showed reduced migration rates.  
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Fig. 4.9 Dose response curve of plasma induced migration of MSC. Transmigration of MSC 
across 8 µm pore membrane was determined in a 48 well Boyden chamber type assay towards 1% 
human plasma (A) or different concentrations of human plasma (B) after 6 hours. -/- represents no 
chemotactic agent in the upper and lower wells, -/+ the presence of human plasma (1%) in the 
lower well only, +/+ the presence of human plasma (1%) in both upper and lower wells. Results are 
shown as percentage of migrated cells. Values are means ± SD, n= 3.  
 
Influence of membrane pre-coating on transmigration activity of MSC 
 
To test which extracellular matrix substance (ECM) causes best adherence and migration 
of MSC, the chemotaxis membrane was pre-coated with various extracellular substances. 
The substances and its concentrations to be tested were narrowed down to human 
fibronectin (Fn), vitronectin (Vn), laminin (Ln), poly-L-lysine (PLL) depending on the results 
obtained from the chemokinetic migration experiments (data not shown). Fn, Ln and Vn 
pre-coatings resulted in quantifiable migration rates whereas pre-coating with PLL showed 
a reduced migration rate (Fig. 4.10). The spontaneous migration was absent in Vn pre-
coating and Fn and Ln pre-coatings showed a lower background migration compared to 
the plasma induced migration.  
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Fig. 4.10 Transmigration of MSC on different pre-coatings. Chemotaxis membrane (8 µm) was 
pre-coated with Fn (1 µg/ml) or Vn (100 ng/ml) or Ln (100 ng/ml) or PLL (10 µg/ml) for 2 hours at 
37°C. Migration of MSC across the pre-coated membrane towards control substance (DMEM/0.1% 
BSA) or human plasma (1%, diluted in DMEM) was determined after 6 hours in a Boyden chamber 
type assay. Results are shown as percentage of cells migrated (Means ±SD, n=3). Statistical 
significance between the groups are represented by asterisks * p<0.01, *** p<0.0001. 
 
Kinetics of MSC migration  
 
The migration behaviour of MSC was further characterized by the time taken to migrate 
across Laminin pre-coated membranes towards human plasma. The cells were seeded in 
equal numbers in each well (2.5x10
4 cells/well) and migration percentage was analysed at 
different time points. The maximum migration was obtained after 4 hours and it plateaus 
until 8 hours (Fig. 4.11).  
 
 
Fig. 4.11 Kinetics of MSC 
migration. Transmigration of 
MSC across Ln (100 ng/ml) pre-
coated 8 µm pore sized 
membrane towards human 
plasma (1%) in a Boyden 
chamber type migration assay 
was determined at the indicated 
intervals. Results are expressed 
as percentage of migrated cells 
(means ± SD, n= 4-5). Statistical 
significance between the groups 
are represented by asterisks *** 
p<0.0001. 
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Influence of cell concentration on transmigration of MSC 
 
Cell concentration could influence migration behaviour in many aspects. Certain kinds of 
cells could migrate only as sheets whereas others migrate individually. In order to find out 
which concentrations give a valid response in chemotactic migration assay with MSC, 
different cell numbers were added for a constant migration period and chemotactic agent 
(human plasma). The cells were seeded in different cell numbers between 500 and 5x10
4 
cells per well in a Boyden chamber type assay and were allowed to migrate towards 
human plasma for 6 hours. MSC were found to migrate at similar percentages at all cell 
densities tested. The migration percentage and number of cells seeded were found to be 
linear, i.e., an increase in cell number caused an increase in the number of detectable 
migrated cells (Fig. 4.12). In the following experiments, between 20,000 and 50,000 cells 
were seeded per well. 
 
 
 
Fig. 4.12 Cell concentration curve 
of plasma induced migration of 
MSC. Transmigration of different 
cell concentrations of MSC across 
Ln (100 ng/ml) pre-coated 8 µm 
pore towards plasma (1%) in a 48 
well Boyden chamber type assay 
was determined. Results are 
expressed as percentage of 
migrated cells across the 
concentration (means ± SD, n= 6). 
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4.3.3  Influence of Rho GTPases on chemotactic migration of MSC 
 
Several reports suggested the influence of Rho GTPases in migration of fibroblasts, 
monocytes and cancer cells (Aepfelbacher, et al 1996, Chrzanowska-Wodnicka and 
Burridge 1996, Fritz, et al 2002, Jaffe and Hall 2002, Sawada, et al 2002). The effect of 
inhibition or induction of members of the Rho family (Rho, Rac and Cdc42) on MSC 
migration (inhibition or induction) was tested. For this, MSC were pre-treated with Rho 
GTPase inhibiting toxins Toxin B (inhibits Rho, Rac and Cdc42), Lethal toxin (LT, inhibits 
Rac and Cdc42), and Y27632 (inhibits Rho) and Rho GTPase inducers LPA (Ridley and 
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Hall 1992), S1P or Cytochalasin D (Cyto D, inhibits actin polymerization) in a Boyden 
chamber type migration assay. LT, Toxin B, and Cyto D treatment significantly reduced 
the plasma induced migration (Fig. 4.13). A similar inhibitory effect was obtained with Rho 
GTPase inducers, LPA, and S1P treatment (Fig. 4.13). However, inhibition of Rho by 
Y27632 showed a significant increase in the migration rate of MSC (Fig. 4.13). 
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Fig. 4.13 Influence of Rho GTPase inhibition on chemotactic migration of MSC. MSC were 
pre-treated with Y27632 (10 µM), Cytochalasin D (10 ng/ml), Lethal Toxin (LT, 100 ng/ml), Toxin B 
(Tox B, 100 ng/ml), Lysophosphatidic acid (LPA, 25 µM), Sphingosine-1-phosphate (S1P, 10 µM) 
for 2 hours at 37°C, 5% CO2. Transmigration of pre-treated or untreated MSC across 8 µm pore 
membrane towards human plasma (0.5%) in a Boyden chamber type assay was determined after  
6 hours (Means ± SD, n= 3-4). All treated groups showed statistically significant differences to 
control. Statistical significance between the groups is represented by asterisks ** p<0.001, *** 
p<0.0001. 
 
4.3.4  Effect of Rho inhibition on serum induced MSC migration 
 
Since Rho inhibition with Y27632 (chemical Rho activated kinase inhibitor) markedly 
elevated the migration capacity of MSC, an experiment was done to investigate if a similar 
increase in migration occurs when Rho is inhibited. To inhibit Rho, the MSC were treated 
with a cell permeable form of C3 transferase toxin, C2I-C3 (inhibits Rho by ADP-
ribosylation), which resulted in a significant rise in the migration rates of MSC in 
comparable amounts with Y27632 treatment (Fig. 4.14 ).  
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Fig. 4.14 Dose response curve of plasma induced 
migration of pre-treated and untreated MSC. MSC were 
untreated or pre-treated with C2I-C3 (1000 ng/ml) or 
Y27632 (10 µM) for 2 hours at 37°C, 5% CO2 and 
transmigration across  Ln (100 ng/ml) pre-coated 8 µm 
pore membrane towards human plasma (1%) was 
determined in a  Boyden chamber type assay after 6 hours. 
Results are expressed as percent of cells migrated. Means 
± SD, n= 3. Statistical significance between the groups are 
represented by asterisks * p<0.01, ** p<0.001.  
 
 
 
 
 
4.3.5  Dose response curve of C2I-C3 
 
The inhibition of Rho by C2I-C3 significantly increased the migration rate of MSC. In order 
to determine the optimal concentration of C2I-C3 for MSC pre-treatment, dose response 
studies were carried out. For that, MSC were pre-incubated with different concentrations 
of C2I-C3 and their migration response was determined by chemotactic migration assay. 
Surprisingly, the migration percentage of MSC constantly increased over entire dose 
range of C2I-C3 examined (Fig. 4.15).  
 
Fig. 4.15 Dose response curve of 
C2I-C3 pre-incubation and 
migration of MSC. MSC were pre-
treated with various concentrations 
of C2I-C3 (3 to 1000 ng/ml) for 2 
hours at 37°C, 5% CO2,  and the 
transmigration across Ln (100 
ng/ml) pre-coated 8 µm pore 
membranes in a Boyden chamber 
type assay  towards human plasma 
(1%) was determined after 6 hours. 
Results are expressed as 
percentage of migrated cells across 
the concentration. Results are 
represented as Means ± SD, n= 3.  0
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4.3.6  Influence of Rho inhibition on chemotactic and chemokinetic migration of 
MSC 
 
In order to explore if the increased migration rate of MSC after Rho inhibition is rather 
chemotactic than chemokinetic, migration of MSC with or without a concentration gradient 
of human plasma was determined in a Boyden chamber type migration assay. For this, 
MSC were pre-treated with Rho inhibiting toxin C2I-C3 and seeded in the upper wells of 
the chemotactic chamber. There was a significant increase in the percentage of migrated 
MSC after pre-treatment with C2I-C3, independent of the plasma gradient (Fig. 4.16). 
Thus, increased migration of MSC after Rho inhibition is both chemotactic and 
chemokinetic nature.  
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Fig. 4.16 Influence of Rho inhibition 
on chemotactic and chemokinetic 
migration of MSC. MSC were pre-
treated with C2I-C3 (1000 ng/ml) for 2 
hours at 37°C, 5% CO2. Migration of 
MSC untreated or C2I-C3 pre-treated 
MSC towards human plasma (1%) 
across 8 µm pore membrane was 
determined in a Boyden chamber type 
migration assay after 6 hours. Results 
are shown as percent of cells migrated. 
(Means ± SD, n= 3). +/+ indicates 
presence of human plasma added to 
both upper and lower wells, -/- indicates 
absence of plasma in both upper and 
lower wells, -/+ indicates plasma added 
only to the lower well. Statistical 
significance between the groups are 
represented by asterisks ** p<0.005, *** 
p<0.0001.  
 
4.3.7  Influence of up or down regulation of Rho GTPases on MSC migration 
 
From the above experiments, it was hypothesized that Rho inhibition induces plasma 
induced migration of MSC whereas Rac or Cdc42 inhibition caused a decrease in 
migration (Fig. 4.13). Therefore, to investigate the influence of Rac induction and 
subsequent Rho inhibition on the migration rate of MSC, the cells were treated with LPA to 
induce Rho, Rac and Cdc42 and subsequently with C2I-C3 or Y27632 to inhibit Rho. The 
migration determined by a Boyden chamber type migration assay after pre-treatment with 
LPA alone showed a 3-fold decrease in the migration rate. In contrast, treatment with LPA 
and then with C2I-C3 showed a significant 3-fold increase in the migration rate of MSC 
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(Fig. 4.17). Interestingly inhibiting Rho by treatment with both C2I-C3 toxin and Y27632 
showed an increase in the migration rate as either together or alone (Fig. 4.17). However, 
inducing Rho, Rac and Cdc42 by LPA and subsequent inhibition of Rac and Cdc42 by LT 
had no impact on the migration potential of MSC (Fig. 4.17).  
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Fig. 4.17 Inhibiting Rho and elevating Rac and Cdc42. MSC were pre-treated with C2I-C3 (1000 
ng/ml), Y27632 (10 µM), LT (100 ng/ml) and LPA (25 µM) for 2 hours at 37°C. In case of pre-
treatment with two substances LPA and C2I-C3 or LPA and LT, the cells were pre-treated first with 
LPA for 2 hours and subsequently with C2I-C3 or LT for another 2 hours at 37°C. In cells treated 
with C2I-C3 and Y27632, the substances were added together for 2 hours at 37°C. The 
transmigration of untreated or pre-treated MSC towards human plasma (0.3%) across Ln (100 
ng/ml) pre-coated 8 µm membrane was determined after 6 hours. The results are expressed as 
means ± SD, n= 3. Statistical significance between the groups are represented by asterisks * 
p<0.01, ** p<0.003, *** p<0.0001. 
 
Rho inhibition by C2I-C3 toxin or Y27632 was found to increase significantly the migration 
rate in MSC. To confirm independently this modulatory role of Rho on MSC migration, 
MSC were stably transduced with Rho GTPase cDNA isoforms (c.a. and d.n.) and 
analysed for their chemotactic migration capacity by Boyden chamber type migration 
assay. MSC transduced with control vector showed similar migration percentage with the 
non-transduced cells (Fig. 4.18). Interestingly, RhoV14 (c.a. Rho) transduced MSC 
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showed a significant decrease in the migration rate, whereas, MSC transduced with C3 
transferase (d.n. Rho) showed a significant increase migration towards human plasma 
(Fig. 4.18), a result which correlates with the increased migration percentage obtained 
with MSC treated with C2I-C3 toxin.  
 
 
0
2
4
6
8
10
12
14
16
18
20
Non-
transduced
SIEW
transduced
SIEW-Rho
V14
transduced
SIEW-C3
transduced
P
e
r
c
e
n
t
 
o
f
 
c
e
l
l
s
 
m
i
g
r
a
t
e
d
**
***
0
2
4
6
8
10
12
14
16
18
20
Non-
transduced
SIEW
transduced
SIEW-Rho
V14
transduced
SIEW-C3
transduced
P
e
r
c
e
n
t
 
o
f
 
c
e
l
l
s
 
m
i
g
r
a
t
e
d
** **
*** ***
Fig. 4.18 Transduction with C3 
elevates chemotactic migration 
of MSC. MSC were lentivirally 
transduced with control vector 
(SIEW), constitutively active form 
of Rho (SIEW-RhoV14) and C3 
transferase (SIEW-C3) and the 
transmigration across Ln (100 
ng/ml) pre-coated 8 µm pore 
membrane was determined in a 
48 well Boyden chamber type 
assay towards human plasma 
(1%) after 6 hours. Results are 
expressed as percent of cells 
migrated (Means ± SD, n= 6). 
Statistical significance between 
the groups are represented by 
asterisks ** p<0.001, *** 
p<0.0001. 
 
4.3.8  Influence of Rho on migration of MSC towards growth factors and 
phospholipids 
 
In order to examine individual chemoattractants for MSC instead of using a complex 
mixture of factors in human plasma, the chemotactic activity of growth factors (Platelet 
derived growth factor; PDGF, Hepatocyte derived growth factor; HGF) or serum 
phospholipids (LPA, S1P) towards MSC was determined by Boyden chamber type 
migration assay. In addition, the effect of Rho inhibition on MSC migration towards such 
factors was determined. MSC were pre-treated with or without the Rho inhibiting toxin C2I-
C3 and the cells were analysed for the migration towards human plasma, PDGF, HGF, 
LPA and S1P. Untreated MSC showed migration response of 0.1 to 0.3% of migrated cells 
towards PDGF, HGF, LPA, and S1P. Whereas, treatment of MSC with  C2I-C3 showed 
approximately 10-fold increase in the migration percentage towards growth factors 
(PDGF, HGF) and serum phospholipids (LPA, S1P) shown in Fig 4.19.  
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Fig. 4.17 C2I-C3 pre-treatment elevates chemotactic migration of MSC. MSC were pre-
incubated without (open bars) or with C2I-C3 (1000 ng/ml) (closed bars) and the transmigration 
across Ln (100 ng/ml) pre-coated 8 µm pore membranes in a Boyden chamber type assay was 
determined towards human Plasma (1%), PDGF (10 ng/ml), HGF (10 ng/ml), LPA (50 µg/ml) and 
S1P (10 µg/ml) after 6 hours. Results are expressed as percentage of migrated cells across the 
concentration (Means ± SD, n= 4). ). Statistical significance between the groups are represented by 
asterisks ** p<0.001, *** p<0.0001. 
 
4.3.9  Effect of Rho inhibition on transendothelial migration of MSC 
 
Rho inhibition significantly increased the migration rate of MSC in a chemotactic model 
where MSC migrated through a membrane. To simulate more closely the physiological 
situation of transendothelial migration, the ability of MSC to cross endothelial cells 
(HUVEC) pre-coated on a porous membrane was determined in a transwell migration 
assay. In this experimental setting, MSC were treated without or with Rho inhibiting toxin 
C2I-C3 and their migration across an endothelial cell layer through porous membrane 
coated with collagen (0.1%) towards plasma was determined. This analysis revealed that 
MSC pre-treated with C2I-C3 significantly elevated the transmigration rate of MSC also 
through the endothelial layer (HUVEC) towards human plasma as represented in Fig. 
4.20.  
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Fig. 4.20 Induction of MSC transendothelial migration. MSC were pre-treated without or with 
C2I-C3 (1000 ng/ml) for 2 hours at 37°C, 5% CO2. Transmigration of MSC across endothelial layer 
(HUVEC) through 8 µm pore membrane towards human plasma (1%) was determined after 6 
hours. Results are expressed as percent of cells migrated (Means ±SD, n=3). +/+ indicates human 
plasma added to both the upper and lower wells, -/+ indicate human plasma added only to the 
lower well. Statistical significance between the groups are represented by asterisks ** p<0.03. 
 
4.3.10  Effect of Rho GTPases on MSC cytoskeleton 
 
Since Rho GTPases has been reported to be involved in migration and organization of 
cytoskeleton (Fukata, et al 2003, Nobes and Hall 1995), and the chemotactic migration 
experiments showed a significant difference in the migration rate, the effect of the Rho 
AB AB
 
Fig 4.21 Effect of Rho activation on actin organization in MSC. Actin and paxillin reorganization 
in MSC treatment without (A) or with LPA (10 µg/ml for 2 hours) treatment (B) was visualized by 
immunostaining with phalloidin-TRITC (red) for actin and anti-paxillin-FITC (green). Magnification 
400 x. 
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GTPases on cytoskeletal organization of MSC was determined. For this, MSC were 
treated without or with lysophosphatidic acid (LPA), and the organization of F-actin and 
paxillin was visualized by immunostaining. The control cells showed F-actin and paxillin 
localized at focal adhesion points (Fig. 4.21 A). Whereas in LPA treated cells, the actin 
filaments are more organized forming stress fibres resulting in increased numbers of focal 
adhesion points. Thus activation of Rho GTPases in MSC by LPA treatment affects the 
organization of actin and focal adhesion protein paxillin (Fig. 4.21 B). 
 
The previous experiment showed the influence of Rho GTPase activation (Rho, Rac, and 
Cdc42) by LPA on MSC cytoskeleton. Since inhibition of Rho function by C2I-C3 or Rho 
kinase inhibitor Y27632 or d.n. Rho (RhoN19) resulted in a significant increase in 
chemotactic migration of MSC, its effect on cytoskeletal organization was determined 
here. MSC treated with Rho inhibitor C2I-C3 toxin was analysed for F-actin organization 
and paxillin. Staining for F-actin with Phalloidin-TRITC showed untreated MSC with F-
actin filaments arranged in an organized fashion running throughout the cell surface (Fig. 
4.22 A). Rho inhibition in MSC changed the pattern of actin organization resulting in a 
more meshwork like arrangement of actin filaments (Fig. 4.22 B). 
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Fig. 4.22 Disruption of F-actin and paxillin by C2I-C3 treatment. Actin organization in MSC pre-
treated without (A) or with (B) Rho inhibitor was visualized by staining with Phalloidin-TRITIC. 
Paxillin distribution in untreated (C) or Y27632 treated (D) MSC were determined by 
immunofluorescent staining with anti-paxillin antibodies coupled to fluorescein isothiocyanate 
(FITC). C2I-C3 (Rho inhibitor) pre-treated MSC were analysed for their migration towards human 
plasma (1%) and actin organization in the migrating cells was visualized by Phalloidin-TRITC (E). 
The pre-treatment time for each was 2 hours at 37°C, 5% CO2. The arrows in C and D indicate the 
paxillin distribution. Magnification 400 x. 
 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  834.0 RESULTS 
In order to find out the effect of Rho inhibition on other cytoskeleton associated proteins, 
the distribution of paxillin in Rho inhibited cells were determined. Consistent with the 
unorganised actin filaments, the distribution of paxillin staining was altered in Rho inhibitor 
treated cells (Fig. 4.22 C and D). However, when Rho inhibited MSC (treated with C2I-C3) 
were induced with plasma, they migrated towards plasma, forming lamellipodia and 
leading edge like structures (Fig. 4.22 E). 
 
Rho GTPase activation by LPA, or inactivation of Rho by C2I-C3 showed a significant 
change in the morphology of MSC cytoskeleton. To decipher the effect further and to 
confirm the cytoskeletal effects caused by Rho GTPase modulation, MSC were 
microinjected with RhoV14 (c.a. Rho) and C3 (d.n. Rho) cDNAs. Injection was done into 
the nucleus of MSC. Effective microinjection and expression of the cDNAs was controlled 
by the expression of eGFP expression, which is present downstream to the Rho GTPase 
genes. Elevating the amount of active Rho by RhoV14 microinjection led to increased 
stress fibre formation in MSC (Fig. 4.23 B). On the contrary, inhibiting the Rho function by 
C3 transferase microinjection led to disoriented actin filaments showing short, thin and 
unorganized F-actin structures as observed with C2I-C3 toxin treatment (Fig. 4.23 C). 
These results indicate that one of the biological functions of these Rho proteins is to 
control actin organization. 
 
A C B A C B
 
Fig. 4.23 Microinjection of MSC with Rho cDNA isoforms. Immunofluorescent staining of F-
actin of MSC with Phalloidin-TRITC after microinjection with 10 µg/ml of Rho cDNA isoforms. 
Control vector (A), RhoV14 (B), and C3 (C). Magnification 400 x.  
 
The previous data indicate that Rho inhibition significantly increased the chemotactic 
migration of MSC and changed its cytoskeleton (actin) and a related protein, paxillin. To 
determine the effect of Rho further on MSC morphology, MSC were transduced with 
pseudotyped lentivirus coding for constitutively active Rho (RhoV14) and C3 transferase 
(Rho inhibiting toxin gene from C. limosum) driven by SFFV promoter, to stably over 
express or inhibit Rho and their effect on morphology of MSC was determined. The 
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transduction efficiency was controlled by GFP expression and it was between 20 and 60% 
of total cells seeded. The transduction of MSC with active Rho or C3 transferase resulted 
in change in morphology of the cells after 48 hours of transduction as shown in Fig. 4.24. 
RhoV14 transduced cells were flat and spread (Fig. 4.24 D and E). In contrast, 
transducing MSC with C3 transferase which inhibits Rho, induced cell retraction, loss of 
contact with neighbouring cells, resulting in rounded morphology with decreased growth 
rate (Fig. 4.24 F and G).  
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Fig. 4.24 Rho GTPases modify the morphology of MSC. Morphology of MSC (A). 
Representative microscopic pictures of lentivirally transduced MSC with control vector (B and C), 
constitutively active Rho, RhoV14 (D and E), C3 transferase to inhibit Rho (F and G). A, B, D and F 
represents phase contrast and C, E and G represent fluorescent microscopic images. Transfected 
cells were identified by the GFP expression in the lentiviral expression vector. Representative 
pictures are shown for each condition. Magnification 100 x. 
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4.4  Role of Rho GTPase activation in endothelial cells for progenitor cell 
migration and homing 
 
4.4.1  Expression of Rac mutant transgene by retroviral vector 
 
To validate the functionality of the cDNAs used for retroviral expression of mutant 
GTPases, GTPase activity was determined in a pull down assay based on Western Blot 
analysis. The active form of Rac was pulled down using GST-Pak1-PBD as described in 
3.2.11. GST-Pak1-PBD discriminates between GTP and GDP bound forms of Rac by 
binding only to GTP bound form of Rac (active Rac). 293T cells were transiently 
transfected with expression vectors encoding Myc-tagged constitutively active Rac 
(RacV12) or dominant negative Rac (RacN17) as well as a control expression vector. Cell 
lysates were prepared and incubated with GST-Pak1-PBD fusion protein, 48 hours after 
transfection. Binding of the Rac protein was analysed by recovery of the fusion protein on 
glutathione Sepharose followed by Western Blot analysis in a 12% polyacrylamide gel 
using an anti-Rac antibody. The active Rac was obtained in cells transfected with vectors 
encoding active Rac (RacV12) and in control vector transfected cells. The two bands 
shown in the result are due to the fact that anti-Rac antibody identifies both endogenous 
and Myc-tagged Rac which has a higher molecular weight than the endogenous form (Fig. 
4.25). 
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Fig. 4.25 Immunoblot analysis of Rac expression. Representative immunoblot of Rac 
expression in 293T cells transfected with Rac cDNA isoforms (constitutively active and dominant 
negative). The cells were analysed 48 hours after transfection. Total Rac represents both active 
and inactive Rac in the transfected cells. To pull down active Rac (GTP bound Rac), the 
transfected cell lysates were incubated with 20 µg of GST-Pak1-PBD and then precipitated with 
glutathione-Sepharose beads. 
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4.4.2  Expression of Rho mutant transgene by lentiviral vector 
 
The expression and GTPase activity of the mutant Rho cDNA was determined in a 
Western Blot analysis. The active form of Rho was pulled down using GST-Rhotekin-RBD 
as described in 3.2.11 GST-Rhotekin-RBD specifically binds to GTP bound form of the 
Rho GTPase (active Rho). 293T cells were transiently transfected with expression vectors 
encoding Myc-tagged constitutively active Rho (RhoV14) or dominant negative Rho 
(RhoN19) as well as a control expression vector. Cell lysates were prepared and 
incubated with GST-Rhotekin-RBD fusion protein, 48 hours after transfection. Binding of 
the Rho protein was analysed by recovery of the fusion protein on glutathione Sepharose 
followed by Western Blot analysis in a 12% polyacrylamide gel using an anti-Rho 
antibody. The two bands in the result are due to the fact that anti-Rho antibody identifies 
both endogenous and Myc-tagged Rho which has a higher molecular weight than the 
endogenous form (Fig. 4.26).  
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Fig. 4.26 Immunoblot analysis of Rho expression. Representative immunoblot of Rho 
expression in 293T cells transfected with Rho cDNA isoforms (constitutively active and dominant 
negative). The cells were analysed 48 hours after transfection. Total Rho represents both active 
and inactive Rho in the transfected cells. To pull down active Rho (GTP bound Rho), the 
transfected cell lysates were incubated with 40 µg of GST-Rhotekin-RBD and then precipitated with 
glutathione-Sepharose beads. 
 
4.4.3  Role of Rho in Endothelial cells (HUVEC) during extravasation 
 
Transduction of HUVEC endothelial cells with Rac and Rho cDNA isoforms 
 
The endothelial cells are a major interacting partner during the homing process. In order to 
determine whether Rho GTPases activity in the endothelial cells might also modulate 
migration and homing of progenitor cells, HUVEC were subjected to transduction with 
constitutively active Rac (RacV12) and constitutively active Rho (RhoV14) cDNAs using 
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pseudotyped retrovirus as described in 3.2.8.2. The transduction efficiency was analysed 
by flow cytometry for the expression of eGFP reporter gene in the transduced HUVEC 
(Fig. 4.28). 
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Fig 4.28 Transduction of HUVEC with retroviral expression vectors. HUVEC transduced with 
control vector, constitutively active Rac (RacV12) and constitutively active Rho (RhoV14) were 
analysed for their transduction efficiency by flow cytometry. The results are expressed as means ± 
SD, n=3. A represents mean values + SD of triplicate experiments and B shows representative flow 
cytometric evaluation.  
 
4.4.4  Regulation of gene expression as determined by microarray analysis 
 
Microarray hybridization technology was used as a tool to determine the modification in 
the regulation of gene expression after Rho GTPase modulation in endothelial cells 
(HUVEC). HUVEC were stably transduced with constitutively active Rac (RacV12) and 
constitutively active Rho (RhoV14) using retroviral expression vectors. 48 hours after 
transduction, RNA was isolated from the cells and cDNA synthesized with the fluorescent 
labelled nucleotides and hybridized to a microarray. 20,000 genes were analysed in the 
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microarray. The threshold was set at 2 fold increase or decrease. Overexpression of 
active Rho was found to affect a number of genes compared to overexpressed active Rac 
in HUVEC (Table 4.3). 
 
30 129
RacV12
c.a.
90 303
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Table 4.3 Regulation of gene expression as determined by microarray analysis. 
This table shows the number of regulated genes after overexpression of constitutively active Rho 
(RhoV14) or constitutively active Rac (RacV12), determined by microarray analysis. c.a. represents 
constitutively active. 
 
4.4.5  Genes Regulated by modulation of Rho GTPase in HUVEC 
 
Modification of Rho GTPase level in HUVEC caused a significant change in the gene 
expression profile. A number of genes were up regulated. When active Rho (RhoV14) was 
overexpressed, group of homing molecules, growth factors and receptors, extracellular 
matrix molecules and cytoskeletal proteins were up regulated (Table 4.4, Table 4.5).  
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CD44 antigen (homing function and Indian blood group
system) CD44 AJ251595
2
E-selectin ELAM, ESEL, CD62E,
LECAM2
NM_000450 4.01
Intercellular adhesion molecule 2 CD102 NM_000873 2.186
Collagen, type IV, alpha 1 COL4A1 NM_001845 2.178
Procollagen (type III) N-endopeptidase PRSM1, KIAA0047 NM_002768 2.11
Fibronectin 1 FN, CIG, FINC AJ276395 -13.79
Interleukin 8 IL8 2.186
Angiopoietin 1 ANGPT1 AF209975 2.023
Plasminogen activator, urokinase URK K03226 2.913
Myeloid leukemia factor 2 MLF2 NM_005439 2.58
Interferon (alpha, beta and omega) receptor 2 IFNABR L41944 -2.089
Ras-related C3 botulinum toxin substrate 2 (rho family,
small GTP binding protein Rac2)
EN-7 NM_002872 4.778
RAB5C, member RAS oncogene family RAB5C NM_004583 2.74
Rab acceptor 1 (prenylated) RABAC1 NM_006423 2.268
G protein beta subunit-like GBL NM_022372 2.551
Cytoskeleton-associated protein 1 CKAP1 BC005969 2.822
Cathepsin Z CTSX AF073890 2.427
Capping protein (actin filament) muscle Z-line, beta CAPB, CAPZ, CAPPB NM_004930 2.365
beta-actin; Human mRNA for beta-actin. ACTB X00351 2.333
Talin 1 TLN NM_006289 3.726
Tubulin, beta, 2 TUBB2 BC004188 2.104
Actin, gamma 2, smooth muscle, enteric ACTE, ACTA3, ACTSG NM_001615 2.042
Tropomyosin 2 (beta) TPM2 NM_003289 2.96
Actin binding LIM protein 1 ABLIM BC002448 -2.341
Homing molecules
Genes regulated in HUVEC by overexpression of active Rho (RhoV14) as determined by microarray 
analysis 
Description Common Name Genebank
Fold 
expression
Extracellular matrix proteins
Growth factors
Small GTPases associated proteins
Cytoskeleton associated proteins
 
Table 4.4 Genes regulated by RhoV14 (c.a.) in HUVEC. The table represents the homing, 
cytoskeleton, growth factors and extracellular matrix protein genes modulated by overexpression of 
constitutively active Rho (RhoV14) in HUVEC.  
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Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) CD61, GP3A, GPIIIa M35999 2.125
Tumor necrosis factor receptor superfamily, member 10b TNFRSF10B AF153687 2.715
Plasminogen activator, urokinase receptor PLAUR AY029180 2.245
Myeloid leukemia factor 2 MLF2 NM_005439 2.055
Fibroblast growth factor 2 (basic) BFGF, FGFB, HBGH-2 NM_002006 -2.04
Ras-related C3 botulinum toxin substrate 2 (rho family,
small GTP binding protein Rac2)
EN-7 NM_002872 3.971
Rho GDP dissociation inhibitor (GDI) alpha GDIA1 D13989 3.22
G protein beta subunit-like GBL NM_022372 2.033
Cell division cycle 42 (GTP-binding protein, 25kD) CDC42 NM_015858 -9.386
RAB5C, member RAS oncogene family RAB5C NM_004583 -3.333
Integral membrane protein 1 TMC NM_002219 2.34
Capping protein (actin filament) muscle Z-line, beta CAPB, CAPZ, CAPPB NM_004930 2.639
Talin 1 TLN, KIAA1027 NM_006289 2.556
Plasminogen activator, urokinase URK K03226 2.547
Catenin (cadherin-associated protein), beta 1 (88kD) CTNNB1 NM_001904 2.343
beta-actin; Human mRNA for beta-actin. ACTB X00351 2.037
Catenin, beta-interacting protein 1 ICAT NM_020248 -2.278
BCL2-like 1 BCL2L1 NM_001191 2.28
Signal transducer and activator of transcription 2, 113kD STAT113 NM_005419 2.33
Fold 
expression
Cytoskeleton associated proteins
Transcription factors
Genes regulated in HUVEC by overexpression of active Rac (RacV12) as determined by microarray 
analysis 
Homing molecules
Growth factors
Small GTPases associated proteins
Membrane associated protein
Description Common Name Genebank
 
Table 4.5 Genes regulated by RacV12 (c.a.) in HUVEC. The table represents the homing, 
cytoskeleton, growth factors and extracellular matrix protein genes modulated by overexpression of 
constitutively active Rac (RacV12) in HUVEC. 
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4.4.6  lation of E-selectin dependent HPC rolling and adhesion in endothelial 
cells 
F-1α for 4 hours to induce the expression of E- Selectin (Doukas and 
ober 1990).  
 
istical significance between the groups are 
presented by asterisks ** p<
Modu
 
To investigate further if the Rho GTPase mediated change in gene expression of HUVEC 
as revealed by microarray experiments plays a role in the adhesion or migration of HPC, 
rolling and adhesion of HPC to the Rho modulated HUVEC was determined under shear 
stress conditions in a flow chamber assay. Retrovirally transduced HUVEC with either 
control vector, constitutively active Rac (RacV12) or constitutively active Rho (RhoV14) 
was coated on a glass slide and mounted on a flow chamber system. HUVEC were 
treated with TN
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4.29 Modulation of E-selectin dependent HPC rolling and adhesion in endothelial cells. 
Rolling and adhesion of HPC on the Rho GTPase modulated HUVEC was determined in a flow 
chamber assay. HUVEC transduced with control vector, constitutively active Rac (RacV12) or 
constitutively active Rho (RhoV14) was used. HUVEC were stimulated 4 hours prior to the 
experiment with TNF-1α (10 ng/ml). HPC were flushed over the HUVEC layer at a shear stress of 
0.1dyn/cm
2 for 10 minutes and the number of adhered HPC was determined. The shear stress was 
increased to 2 dyn/cm
2 in the next 10 minutes and the number of cells adhered to the endothelial 
cell (HUVEC) layer was determined. The results are expressed as number of cells adhered to the 
ndothelial cell layer (Means ±SD, n=3). Stat e
re 0.006, ***p<0.0002. 
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HPC were flushed over the endothelial cell layer at a constant shear stress and the 
adhered cells were counted. A significant increase in the binding of HPC to active Rho 
(RhoV14) expressing HUVEC was found (Fig. 4.29). The increased adherence of HPC to 
Rho activated HUVEC, could be attributed to E-selectin mediated binding since blocking 
of E-selectin by anti-E-selectin antibody was found to cause suppression in the binding of 
PC to HUVEC.  
 
H
 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  935.0 DISCUSSION 
5.0 DISCUSSION 
 
In medicine, autologous and allogeneic stem cell transplantation of hematopoietic stem 
cells is performed to rescue the hematopoietic system in patients after myelo-ablative 
chemo- or radiotherapy. A specific requirement for successful long-term engraftment in 
stem cell transplantation is the migration of transplanted cells from the peripheral blood to 
the bone marrow in a process termed “homing”. In spite of the importance of these 
mechanisms, the signalling processes involved in homing of stem cells are not clearly 
understood. Better understanding of the physiological regulation of stem cell homing is 
however expected to aid in improving the efficiency of stem cell engraftment. Therefore, 
the present study investigated the role of Rho GTPases in the migration of hematopoietic 
and mesenchymal progenitor/stem cells. Furthermore, an approach was taken to analyse 
the involvement of Rho GTPases in endothelial cells, and its relevance for homing of stem 
cells. 
 
Induction of chemotactic migration of MSC by plasma 
 
Migration of stem cells to bone marrow or to sites of tissue injury is a necessary key 
feature for tissue reconstitution. Earlier studies with chemotactic experiments have 
identified the essential role of the SDF-1α/CXCR4 receptor/ligand pair for induction of   
migration in HSC (Aiuti, et al 1997). In MSC, CXCR4 has been reported to be expressed 
to a far lesser degree (Wynn, et al 2004), which may explain the absence of a clear 
response of MSC towards SDF-1α observed in this study. However, Wynn et al. found 
signs of MSC migration towards SDF-1α, which could be attributed to the low level of 
CXCR4 expressed on the surface of MSC isolates used in the study (Wynn, et al 2004). 
Thus, it was necessary to identify alternative chemotactic substances to study MSC 
migration under in vitro conditions.  
 
It was considered that MSC after leaving the bone marrow would have to be attracted 
towards the blood circulation by a physiological activity. The present study defines diluted 
human blood plasma (1%) as a potential chemotactic agent for MSC migration. The fact 
that diluted human plasma is more efficient as chemotactic agent than pure plasma could 
be attributed to several reasons. Firstly, the static in vitro conditions differ from in vivo 
conditions where there is an involvement of shear stress and the presence of other cells 
such as erythrocytes, which interact with the stem cells circulating in the peripheral blood 
to induce their migration and homing. On the other hand, when MSC leave the peripheral 
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blood to enter the tissues, a plasma concentration gradient between the blood vessels and 
the tissues is likely to attract MSC towards the tissues. According to the results of this 
study, human plasma may also contain Rho inhibiting factors that favour the induction of 
MSC migration. It is important that the individual factors in plasma that influence migration 
of MSC are deciphered, e.g. by fractionation and analysis of each fraction for their 
migration inducing potential. 
 
Relevance of methodology used to assess MSC migration 
 
Until now, the literature did not show a methodology which allows induction of MSC 
migration in transwell systems to a comparable degree as with HSC (Fiedler, et al 2004). 
The present study describes a migration method where absolute numbers of migrated 
MSC are assessed (Fiedler, et al 2004, Ruster, et al 2005). This is in contrast to the 
reports showing only the number of migrated cells per microscopic field (Fiedler, et al 
2002). The methodology in the present study applies microscopic enumeration of migrated 
cells on the membrane in situ by a two-step staining procedure and the confirmation of the 
correct transmigrated location of the scored cells. Furthermore, this study shows the 
technical details to differentiate between chemotactic and chemokinetic migration in MSC 
transwell assays. Using the above technique, a migration rate as high as 12% during a 
period of 4 – 6 hours was achieved corresponding to the expected migration efficiency 
and which is the time period when assessing migration of hematopoietic cells, including 
HSC (Peled, et al 1999, Voermans, et al 2001). 
 
Role of extracellular matrix substances in MSC migration 
 
Several reports have demonstrated the role of extracellular matrix (ECM) substances in 
cell migration during tissue injury or repair (del Pozo, et al 1995, Hotchin and Hall 1995, 
Prockop, et al 2000). The question of whether ECM substances might augment MSC 
migration was addressed in this study by the application of different pre-coating 
conditions, such as coating with vitronectin, laminin, and fibronectin. The data show that 
the type of ECM substances influences the induction of chemokinetic and chemotactic 
migration. Chemokinetic migration, corresponding to an unspecific mobilization of the 
cells, and true chemotactic migration, i.e. directed migration towards a chemoattractant, 
have both been determined. Fibronectin or laminin pre-coating have been found to induce 
both chemokinetic and chemotactic migration, whereas a vitronectin pre-coating favoured 
the chemotactic migration of MSC. The ability to differentiate between chemotactic and 
chemokinetic migration brought about by the use of ECM substances should assist the 
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future discrimination of chemotactic versus chemokinetic factors for the migration of MSC 
(Ruster, Grace, et al 2005). In addition, chemotactic migration of MSC was found to be 
independent of cell density or concentration of the seeded cells. 
 
Role of Rho GTPases in the regulation of the cytoskeleton and cellular morphology 
of MSC 
 
Previous studies have reported the involvement of Rho GTPases in the activation of the 
cytoskeleton in fibroblasts, where Rho induced the formation of stress fibres and focal 
adhesion complexes. In addition, Rac and Cdc42 have been shown to control  the 
formation of actin ruffles and spikes of the cytoplasmic membrane respectively 
(Chrzanowska-Wodnicka and Burridge 1996, Kozma, et al 1995, Nobes and Hall 1995, 
Nobes, et al 1995, Ridley and Hall 1992). These cytoskeletal changes brought about by 
Rho GTPases directly relate to the general changes in cell morphology that are 
associated with migration.  
 
The established specific inhibitor of Rho, C3 transferase (Aktories 1997, Aktories and Hall 
1989, Genth, et al 1999, Genth, et al 2003), was used in this study to down regulate Rho 
in MSC. The C3 transferase was applied in a cell permeable form, by fusion with the ecto 
domain of C2 domain of C. botulinum, C2I, to allow entry into target cells, C2I-C3. MSC 
treated with C2I-C3 transferase showed an altered actin organization and finer, shortened 
actin filaments, which indicating that Rho controls the actin filament organization in MSC. 
This effect of Rho inhibition on MSC was confirmed after microinjection of MSC with C3 
transferase cDNA which also resulted in formation of short and thin actin filaments. 
Moreover, time-lapse video microscopic pictures of C3 transferase microinjected MSC 
revealed the emergence of membrane ruffling and lamellipodia like structures in these 
cells. 
 
Nobes and Hall suggested Rac to be the predominantly responsible molecule controlling 
cellular actin organization (Nobes and Hall 1995), Also, Rottner et al and Sander et al 
reported a reciprocal relation of Rho and Rac (Rottner, et al 1999, Sander, et al 1999). In 
extension to these previous findings, the current study shows that a selective inhibition of 
Rho leads to changes in the cytoskeletal structure. However, at this point of time, it cannot 
be excluded that Rho inhibition itself causes an increase in the level of active Rac in MSC.   
 
Further findings in this study nevertheless indicate that increasing the level of active Rho 
in MSC by microinjection of RhoV14 cDNA (c.a. Rho) resulted in stress filaments and 
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focal adhesion-like structures similar to those reported in fibroblasts (Nobes and Hall 
1995). Here, the function of Rho in MSC appears similar to that observed in fibroblasts. 
Moreover, interaction with binding partners of Rho such as guanosine exchange 
factors(GEFs) and GTPase activating proteins (GAPs) which occur in subcellular 
compartments may also play a critical role (Boguski and McCormick 1993) in regulating 
the cytoskeletal organization in MSC. 
 
Rho was reported to have an impact on the formation of focal adhesion complex proteins 
(Chrzanowska-Wodnicka and Burridge 1996, Nobes and Hall 1995, Nobes, et al 1995, 
Ridley and Hall 1992). Accordingly, the present study shows a decrease in the 
concentration of the focal adhesion protein, paxillin, in Rho inhibited MSC. This suggests 
that Rho, in addition to controlling the actin cytoskeleton, is also involved in the regulation 
of focal adhesion complex substances like paxillin-containing structures in MSC. Focal 
adhesion complexes contain components of signal transduction (Clark and Brugge 1995). 
From this, it can be hypothesized that other signalling pathways might be regulated by 
Rho through signal transduction via focal adhesion complexes, e.g. in neighbouring cells 
in MSC. Thus, it can be concluded at this point that by controlling activation of actin and 
paxillin, changes in the activity of Rho result in the altered morphology and migratory 
behaviour of MSC.  
 
Previous studies have reported that inactivation of Rho leads to clustering, detachment 
and cell rounding in fibroblasts (Hotchin and Hall 1995). In addition, Aepfelbacher et al 
showed that active Rho acts as a negative regulator of human monocyte spreading, and 
supports the maintenance of a rounded morphology in those cells (Aepfelbacher, et al 
1996). Whereas, Vicente-Manzanares et al found in 2002 that RhoA activity induced 
contraction of the cell cytoskeleton in lymphocytes and caused rounding of the cells 
(Vicente-Manzanares, et al 2002). These previous findings point towards anchoring 
functions of Rho in fibroblasts, whereas in lymphocytes, Rho activation led to cell 
rounding. The present study reveals that, hours after inhibition of Rho in MSC by either C3 
transferase toxin treatment or by microinjection of C3 transferase cDNA, cell spreading, 
cell flattening, lamellipodia formation and pseudopodial extension were induced similar to 
the reports of analogous changes observed in human neuronal cells (Jalink, et al 1994) or 
monocytes (Aepfelbacher, et al 1996). In contrast, after stable expression of dominant 
negative Rho in MSC by lentiviral vectors and analysis several days later, cell clustering, 
detachment and cell rounding were seen, which is in line with reports in fibroblasts by 
Hotchin et al (Hotchin and Hall 1995, Hotchin and Hall 1996). Therefore, a biphasic role of 
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Rho-mediated cytoskeletal changes is possible. However, it is also possible that after 
inhibition of Rho for longer time periods, adaptation events occur in the cells, or that 
predominance of other Rho GTPases such as Rac determines the phenotypes found. 
Cancelas, et al speculate that the increased pseudopodial extension observed in Rho 
inhibited cells might be due to a defect in tail retraction during migration (Cancelas, et al 
2005). Surprisingly, stable expression of active Rho but not Rac in MSC on the longer 
term also resulted in cell spreading and flattening. Since the overexpression of active or 
negative Rho occurs after 48h, adaptive reactions in the cells resulting in altered activation 
of other Rho GTPases and other signalling chains may have occurred.  Although, the 
morphological changes observed by transient and stable inhibition of Rho in MSC were 
somewhat dissimilar, the effects of Rho modulation on migration of MSC remain unaltered 
which suggests that Rho signals via different pathways to alter the morphology and 
migration.  
 
Effects of Rho inhibition on migration of HPC and MSC  
 
There are several reports about the involvement of Rho GTPases in controlling migration 
in fibroblasts (Chrzanowska-Wodnicka and Burridge 1996), monocytes (Aepfelbacher, et 
al 1996) and cancer cells (Fritz, et al 2002, Jaffe and Hall 2002, Sawada, et al 2002). 
Bacterial toxins from Clostridial species were reported to specifically target and inactivate 
Rho GTPases (Aktories 1997, Aktories and Hall 1989, Genth, et al 1999, Genth, et al 
2003, Waksman 2002) and were used as a tool to study the function of Rho GTPases in 
migration.  
 
Vicente-Manzanares et al reported that simultaneous activation of all the three Rho 
GTPases (RhoA, Rac1, and Cdc42) exhibited different effects on lymphocyte morphology 
and inhibited migration (Matozaki, et al 2000, Vicente-Manzanares, et al 2002). In 
addition, the present study shows that simultaneous inactivation as well of all the three 
Rho GTPases (Rho, Rac, and Cdc42) by treatment with Toxin B inhibited SDF-1α and 
plasma induced migration in HPC and MSC, respectively. However, pre-treatment with the 
more selective inhibitor, lethal toxin which inhibits Rac and Cdc42 but not Rho, was also 
found to inhibit the chemotactic migration of HPC and MSC. In contrast, inhibition of Rho 
alone by C2I-C3 transferase toxin did not affect the chemotactic SDF-1α induced 
migration of HPC but significantly induced the chemokinetic migration of HPC. Although 
chemokinetic migration alone does not possibly define chemotaxis, it has been shown to 
be associated with improved engraftment potential in CD34
+ HPC, which showed better 
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engraftment than their non-migrating counterparts (Peled, et al 1999). Analogously, 
inhibition of Rho also significantly elevated the chemotactic migration response of MSC.  
 
In contrast, stimulation of all the three Rho GTPases by the phospholipids mediators, LPA 
or S1P resulted in inhibition of chemotactic migration of HPC and MSC. LPA was reported 
to be a general inducer of Rho GTPases (Rho, Rac and Cdc42) in fibroblasts (Ridley and 
Hall 1992). LPA synthesized by cells accumulates in extracellular fluids like serum and 
inflammatory exudates (Goetzl and Lynch 2000), and so the cell response could be of 
physiological relevance.  
 
The present study shows that activation of Rho GTPases by LPA by pre-incubation of the 
analysed cells inhibited the SDF-1α and plasma induced migration of HPC and MSC, 
respectively. Moreover, MSC did not display chemotactic activity towards LPA. This 
suggests that Rho GTPase activation has an inhibitory effect on MSC migration. Ishii et al 
reported that LPA modulate actin reorganization through activation of Rho (Ishii, et al 
2000). Furthermore, LPA has been reported to confer chemotactic activation of 
eosinophils, where it caused a transient actin polymerization (Idzko, et al 2004). In 
addition, LPA and S1P were reported to synergistically function via Rho GTPases 
(Whetton, et al 2003). 
 
In this study, inhibition of Rho thus caused a 10-fold increase in the plasma induced 
chemotactic migration of MSC towards LPA and S1P. The result of the present study 
contrasts the report by Sawada et al where LPA induced migration of human ovarian 
cancer cells was inhibited by Rho inhibition (Sawada, et al 2002). This can be explained 
by different physiological environments where the analysed migration occurs. 
Transendothelial migration is facilitated by downregulation of Rho and likely predominant 
Rac activation, whereas interstitial migration which requires closer contacts between 
neighbouring cells and membrane mediated motility would require predominant activation 
of Rho.  
 
In addition, the present study describes that rhPDGF-bb and rhHGF induced MSC 
migration, although less efficient than human plasma. This data corresponds with the 
findings of Fiedler et al that these factors induce MSC chemotaxis (Fiedler, et al 2004, 
Fiedler, et al 2002). The present study however suggests that the migration induction by 
rhPDGF-bb and rhHGF depends on the activation status of Rho (Eriksson, et al 1992, 
Jiang and Hiscox 1997, Nobes, et al 1995, Ridley, et al 1992). 
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Thus, MSC migration is dependent on decreased levels of active Rho. Possibly an 
antagonism exists between the relative activities of Rho and Rac as described with other 
cells (Rottner, et al 1999, Sander, et al 1999). Such antagonism can also explain the 
increased migration rate of MSC, which was measured, when all the three Rho GTPases 
(Rho, Rac, and Cdc42) are induced simultaneously by LPA, followed by Rho inhibition 
with C2I-C3 transferase toxin. It is possible that Rho at least through some part, also 
functions through inhibiting spontaneous adhesion in MSC, when inducing migration. This 
would be consistent with the report of Laudanna et al where Rho was found to be involved 
in integrin mediated cell adhesion in leukocytes (Laudanna, et al 1996). 
 
MSC and SDF-1α induced migration 
 
The low or absence of migration of MSC towards SDF-1α and the low surface expression 
of CXCR4 on MSC reported by Wynn et al correspond to each other (Wynn, et al 2004). 
The latter authors report few migrating MSC towards SDF-1α, which was not seen in this 
study. This may be due to the fact that these authors did not provide absolute numbers of 
transmigrated cells and for the data reported it is possible that there was no quantifiable 
response, such as with 5-10% migrated MSC as in the present study.  
 
SDF-1α has been shown to modify the cytoskeleton in lymphocytes and activate Rho (del 
Pozo, et al 1995). However, RhoA inhibition did not block the SDF-1α induced actin 
polymerization and formation of filopodia-like structure. This situation is analogous to the 
findings in MSC migration, showing inhibition of the migratory phenotype. Moreover, SDF-
1α is produced by MSC themselves (Bleul and al. 1996) and a gradient of SDF-1α 
therefore already exists around MSC making them less responsive to the external gradient 
of SDF-1α in in vitro conditions. In addition, migration might only be a minor aspect of 
SDF-1α function, regulated via Rho, with other major functions left unharmed. 
 
Influence of Rho activation on E-selectin expression  
 
Adhesion of transplanted stem and progenitor cells to the endothelial layer is a pre-
requisite for extravasation when they migrate from peripheral blood to enter the tissue 
(Wojciak-Stothard, et al 1999). Several studies reported E-selectin to be involved in initial 
adhesion, rolling and migration of HPC on bone marrow endothelial cells (Mazo, et al 
1998, Naiyer, et al 1999, Rood, et al 2000). Tumour necrosis factor α (TNF-α) was 
identified to induce E-selectin expression in HUVEC (Nubel, et al 2004).  
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The microarray data of the present study show that overexpression of active Rho 
(RhoV14), but not Rac, elevated the expression level of E-selectin in HUVEC. Moreover, 
constitutively active Rho expression in HUVEC increased the adhesion of HPC on 
HUVEC. Adhesion was chosen as an endpoint since Beekhuizen and van Furth reported 
that adhesion and spreading are pre-requisites and precede the transendothelial migration 
(Beekhuizen and van Furth 1993). In addition, Wojciak-Stothard, et al reported that 
adhesion and spreading of monocytes on endothelial cells are dependent on Rho A-
regulated clustering of E-selectin, and that Rho inhibition by C3 transferase application 
inhibited clustering of E-selectin on the endothelial cell surface and Rac was not found to 
be involved in such regulation (Wojciak-Stothard, et al 1999). However, these experiments 
were not performed under flow conditions like in the present study. 
 
Moreover, the present study proposes in addition to the Wojciak-Stothard et al who 
identified receptor clustering as the regulated activity, that Rho is also involved in the 
induction of E-selectin gene expression in HUVEC. These results are consistent with the 
recent report by Nubel et al that Rho signalling is essential for transcriptional activation of 
E-selectin gene in HUVEC (Nubel, et al 2004). The results of the present study show that 
the adhesion of HPC on Rho activated HUVEC does not occur at comparable levels as in 
of TNF-α induced HPC adhesion. However, HPC also showed increased adhesion on 
TNF-α stimulated HUVEC after Rho activation. This observation points to the situation that 
TNF-α induced surfacing (externalization) of E-selectin is induced by Rho in HUVEC, 
which in turn increases HPC adhesion. In sum, the present study suggests that TNF-α 
acts synergistically with active Rho for increased HPC adhesion on HUVEC through E-
selectin and TNF-α signals through the ‘Rho road’ towards E-selectin.  
 
The increased adhesion of HPC to Rho activated HUVEC might be of clinical relevance 
since E-selectin has been reported to be expressed on small endothelial vessels in 
hematopoietically active tissues in in vivo (Schweitzer, et al 1996). Modification of E-
selectin expression by Rho-GTPases could therefore be considered as a strategy for 
modulation of stem cell homing. In addition, up or down regulation of the other homing 
molecules (CD44, CD102), adhesion and cytoskeletal molecules by constitutive active 
expression of Rac and Rho suggests that it is not a “yes or no” effect but follows an 
intertwined regulatory pathway. The deeper investigation of these interactions might 
reveal further insights on endothelial cell mediated processes in stem cell homing.  
 
Role of Rho GTPases in Migration of Stem and Progenitor Cells  1015.0 DISCUSSION 
Role of Rho GTPases in migration and adhesion of endothelial progenitor cells 
 
Rho GTPases have also been reported to be involved in tumour metastasis, 
vascularization and angiogenesis (van Nieuw Amerongen and van Hinsbergh 2001). Here, 
endothelial progenitor cells are thought to give rise and support the growth of tumour 
associated blood vessels. The present study investigated the function of Rac on 
embryonic endothelial progenitor cells (eEPC) interacting with adherent endothelial cells 
under flow. The adhesion and migration behaviour of cells under shear stress conditions 
in the flow chamber assay simulates an in vivo environment. A decreased adhesion of 
eEPC transduced with active Rac (RacV12) to HUVEC was found. This is in contrast to 
the results with HPC. This might be due to the relatively decreased Rho level as 
discussed above, which facilitates migration of adherent cells rather than the adhesion. 
Complementary to these results employing eEPC transduced with dominant negative Rac 
showed increased adhesion on HUVEC compared to eEPC transduced with a control 
vector. This increased adhesion could potentially also be attributable to an increase in cell 
surface expression of CD44, since this homing molecule was expressed at increased 
levels in Rac inactivated eEPC. In addition, the cyto-morphological changes induced by 
active or negative Rac on eEPC are consistent with the results reported by Nobes et al 
that Rac activation leads to formation of lamellipodia (Nobes and Hall 1995 141).  
 
CONCLUSION 
 
Taken together, migration and homing of stem cells in the tissue is a complex 
phenomenon dependent on multifactorial influence and that Rho GTPases play an 
important role in intracellular signalling during various stages of homing, rolling, adhesion, 
and transmigration of stem cells into the tissues. For a therapeutic model for tissue repair, 
the results of present study show that by modulating the level of Rho GTPases, homing 
processes of MSC to bone marrow and other organs could be improved. Several studies 
reported that transplanted MSC were found circulating or physically trapped in lungs in 
mice (Anjos-Afonso, et al 2004, Barbash, et al 2003, Gao, et al 2001) and thus engrafted 
only at low levels in tissues and organs.  Rho inhibition might be a useful tool to render 
MSC more motile and move better through the capillaries such as in the lungs and thus 
increasing the number of cells arriving at the desired organs such as bone marrow. Thus 
the elucidation of Rho dependent migration of MSC might promote the development of 
new therapeutic approaches for bone repair, tissue regeneration and wound healing. 
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The present study provides insight towards migration and adhesion processes activated 
by Rho GTPases. The data suggest a model (Fig 5.1) where active Rac is involved in 
modulating processes such as rolling of stem cells (MSC) in the peripheral blood and the 
exit of progenitor cells from blood vessels through an endothelial layer. At the sites of 
tissue injury, induction of endothelial cells by TNF-α activates Rho and results in 
increased E-selectin expression on endothelial cells pointing to a role of Rho in 
attachment of stem/progenitor cells to the endothelial layer. Growth factors i.e. PDGF, 
produced at the injury site, would activate Rac, thereby stem cells are induced to migrate 
through the endothelium into the tissues. In all these situations, thus a regulated reciprocal 
balance exists between Rac-induced migration and Rho-induced adhesion which regulate 
the homing and extravasation of stem and progenitor cells. 
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Fig 5.1 Model for the regulation of stem/progenitor cells homing and extravasation by Rac 
and Rho GTPases. Triangular type (◄) symbol represent spatial gradient of factors or activity. 
Arrows indicate directions of blood flow or movement of stem/progenitor cells in the tissue. 
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